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ABSTRACT 
 
Regeneration is a relatively widespread phenomenon in nature, although different organisms 
exhibit different abilities to reconstitute missing structures. Due to the diversity in the extent 
of damage the organisms can repair it has been debated for a long time whether those 
abilities are evolutionary traits that arose independently in multiple organisms or whether 
they represent a by-product of more basic processes. 
To date, due to constant increase in the amount of available genomic information this 
question can be approached by means of comparative genomics by comparing several taxa 
that have different regenerative capabilities.  
Two relatively closely related salamander species, newt, Notophthalmus viridescens, and 
the Mexican axolotl, Ambystoma mexicanum, offer a unique opportunity to compare two 
organisms with well-known regenerative capabilities. Despite their importance for 
regeneration research, relatively little sequence information was available until recently, 
owing mainly to the large sizes of the respective genomes. 
In this work I aimed to create a comprehensive transcriptome assembly of the axolotl by 
sequencing and then assembling the sequence data from a number of tissues and 
developmental stages. I also incorporated available sequence information that mostly comes 
from cDNA libraries sequenced previously. I assessed the completeness of the 
transcriptome by comparing it to a set of available axolotl sequences and found that 96% of 
those have homologs in the assembly. Additionally, I found that 7,568 of 7,695 protein 
families common to vertebrates are also represented in the transcriptome. 
In order to turn the assembly from a merely collection of sequences into a valuable and 
useful resource for the entire research community I first annotated the sequences, predicted 
the open reading frames and protein domains and additionally put together multiple bits of 
information available for each sequence including but not limited to time-course and tissue-
specific expression data and in situ hybridization results. The assembly was thereafter made 
available for the entire axolotl research community through a web portal I developed. Not 
only does the web portal provide access to the transcriptome data, it is also equipped with 
an engine for automated data retrieval, which could facilitate automated cross-species 
bioinformatics analyses. 
The study crossed the boundary between pure bioinformatics and biology as the 
transcriptome allowed for computational comparison of the axolotl and the newt in order to 
identify salamander-specific genes possibly implicated in regeneration and subsequent 
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functional analysis thereof in the lab. Since regeneration closely resembles embryonic 
development in terms of genes involved in both processes, I first identified approximately 
200 homologous contigs in axolotl and newt, which had a predicted open reading frame, but 
did not have homologs in non-regenerating species. The expression profile of one of those 
candidate genes suggested that it had a role in regeneration. I studied the molecular 
function of that gene using CRISPR/Cas system to confirm that it was protein-coding and to 
create knock-out animals to study the effect of gene knock-down and knock-out. Knock-out 
animals exhibited significant delays in both, limb development and tail regeneration. The 
exact mechanism causing this delay is currently being investigated. 
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CHAPTER 
1 
 
INTRODUCTION 
 
1.1 INTRODUCTION TO REGENERATION 
Regeneration – the ability to regrow new body parts to replace the ones that were damaged 
– has been a source of fascination to humans for centuries. The process of regeneration – 
although not always referred to as such – has been known, although not understood, for as 
long as almost three thousand years. Examples of regeneration are illustrated in ancient 
Greek mythology. The god Prometheus was banished after stealing the fire from Olympus 
to give it to the people, chained to a rock and left to be tortured by an eagle that would 
come every night for 30,000 years and pick at his liver. Due to his immortality his liver would 
regenerate the next day ensuring the same punishment night after night.  
The very name of the liver in Greek, ἧπαρ (hepar), after ἠπάοµαι, which means “to repair 
oneself”, clearly states that the ancient Greeks understood that the liver is capable of 
regenerating itself spontaneously after injury. 
Although the human body only has limited regenerative potential, it is a surprisingly widely 
spread phenomenon among a number of organisms. The cornerstone of what now is known 
as regeneration research was laid by during 1700’s by scientists like Abraham Trembley who 
documented the extensive abilities of a freshwater polyp Hydra to regenerate after bisection 
or even dissociation, or René-Antoine Ferchault de Réaumur who described the ability of 
crayfish to regenerate their limbs [DINSMORE 2007]. 
Organisms differ dramatically in the extent of damage they can repair [BROCKES ET AL. 2008], 
an observation that is likely to be evolutionary hierarchical [POSS 2010]. While some lower 
invertebrate organisms such as hydra and planarians are on top of this hierarchy and can 
regenerate an entire organism from a small body fragment (FIGURE 1.1a,b), more complex 
vertebrate organisms are largely incapable of regenerating any lost structures. Moreover, 
regenerative capacities vary greatly even among body parts within the same animal. Within 
the vertebrates however, the most successful regenerating species – the salamanders – can 
easily replace their limbs (FIGURE 1.1c), tails and jaws. 
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a. Planarian regeneration. All thee pieces of a 
transsected animal give rise to a fully normal 
patterned new animal (adapted from 
https://snowbio.wikispaces.com/Planaria+(Platyhe
lminthes)). 
 
b. Hydra regeneration. The head of a 
transsected animal regenerates the foot and 
vice versa (adapted from [TORTIGLIONE 2011]). 
 
c. Samalander limb regeneration. Upon amputation a blastema – mass of presumably 
undifferentiated progenitor cells – is formed at the stump. In the course of regeneration 
the blastema cells give rise to a fully patterned limb (modified from [GOSS 1969]). 
FIGURE 1.1: Regeneration across species. Different species have different regenerative capacities. 
An intriguing question that may help us to better understand the molecular mechanisms 
underlying regeneration is whether regeneration is simply a by-product of normal 
development or if it is an evolutionary trait [GOSS 1969; REICHMAN 1984; WEISMANN 1899]. 
With the recent advances in molecular biology and computational methods we are now able 
to approach this long-standing question as the genomic data of more and more organisms 
including those that regenerate become available and can be used for comparisons.  
If regenerative ability was an evolutionary trait, it would have appeared in all regenerating 
species autonomously from non-regenerating ancestors – an event that is called convergent 
evolution in evolutionary biology [MEYERS ET AL. 2011]. On the other hand, if the ability to 
rebuild lost structures was an ancient trait that was lost in many species in the course of 
evolution and adaptation, then in its original form regeneration must recapitulate embryonic 
development [GOSS 1992]. Results from a wide array of studies have revealed widely shared 
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properties of regeneration across different taxa [BROCKES ET AL. 2008]. These include re-
epithelialization of the wound or the formation of an intact epithelium covering the wound; 
the production of enzymes involved in the remodeling or degradation of the extracellular 
matrix (ECM) – metalloproteases; activation of immune response genes that are up-
regulated early in regeneration; and the presence of cell signaling pathways, e.g. FGF or Wnt 
[GURLEY ET AL. 2008; SÁNCHEZ ALVARADO ET AL. 2006].  
Striking similarities in the molecular mechanisms between regeneration and development 
support the notion that regeneration is rather an epiphenomenon of development and, thus, 
a natural consequence of an accessible developmental program that is re-activated when a 
structure is lost [MARTINEZ ET AL. 2005; MARTIN ET AL. 2004]. 
 
 
1.1.1 EVOLUTIONARY ASPECTS OF REGENERATION 
Irrespective of its origin, a trait must be actively maintained by selection. For regeneration it 
means that several evolutionary criteria must be met: i) the structure must be frequently lost 
in the population as a direct consequence of its habitat or ecological niche; ii) loss of 
structure must negatively impact the fitness of the organism, such that regenerative abilities 
pose some benefit; and iii) there must be a trade-off between advantages and the cost of 
regeneration [BELY ET AL. 2010]. 
A simple example for the first criterion is autotomy – a behavioral trait whereby an animal 
sheds its own appendage, usually for self-defense to avoid entrapment. In a habitat where 
an animal is likely to encounter a predator such a trait is an advantage. 
Not surprisingly, loss of a structure usually has a negative impact on survival due to impaired 
locomotion or decreased feeding or reproduction ability [BELY ET AL. 2010]. However, loss of 
different structures has different effects on the fitness of the organism. While some organs 
are indispensable for survival, the loss of some others may even present an advantage for 
the organism. A few examples thereof are the prolonged lifespan in worms subjected to 
repeated injury [MARTÍNEZ 1996] or increased locomotion in the spider species Tidarren, in 
which the males voluntarily remove one of their two disproportionally large copulatory 
organs [RAMOS ET AL. 2004]. In such cases regeneration would even negatively affect the 
individual.  
Several key points must be taken in consideration concerning the cost of regeneration: i) 
regeneration can be energetically expensive; ii) imperfect regenerate may hinder the 
organism more than the complete absence of the structure [VOLLRATH 1990]; and iii) the 
replacement must be beneficial compared to the absence of the structure and depends on 
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how long the regeneration would take in comparison to the expected longevity [VITT ET AL. 
1986]. While some structures are completely dispensable, such as one or two legs in some 
spiders, an observation that led to a space legs hypothesis [GUFFEY 1999], others are crucial, 
as the individual may die before regeneration completes.  
An alternative view – pleiotropy – claims, however, that the retained ability to regenerate 
does not present an evolutionary benefit, but rather is a by-product of a closely related 
process, such as asexual reproduction or embryogenesis. According to this hypothesis, the 
amputation simply triggers a mechanism shared between regeneration and another process, 
normal growth in cnidarians for example [SÁNCHEZ ALVARADO 2000; SÁNCHEZ ALVARADO ET AL. 
2014].  
The process of positive selection would increase the frequency of an advantageous trait, 
such as regenerative ability, within a population [RIESEBERG ET AL. 2002]. In contrast, a trait 
that does not influence the fitness of an organism is neither subject to positive nor to 
negative selection, which removes deleterious alleles from the population. The hypothesis 
of phylogenetic inertia states that regeneration might have been advantageous at some 
point in the past; is, however, a neutral trait now. Therefore, while it may not have been 
actively retained by pleiotropy, it might simply have been retained passively due to historical 
reasons [BELY ET AL. 2010].  
To us, species that have very limited regenerative potential, the ability to regenerate lost 
appendages seems to be very beneficial. If regeneration is indeed a pleiotropic effect, then a 
pleiotropic breakdown event or decoupling of developmental events must have taken place 
in non-regenerating species such as humans [GALIS ET AL. 2002]. Galis proposed that limb 
regeneration is only possible if the developing limb is not involved in interactions with 
transient structures that cannot be recapitulated later. For example, in amniotes limbs 
develop early and interact with transient embryological structures such as somites. In 
contrast, in amphibians the limb development is delayed and therefore decoupled from such 
interactions [GALIS ET AL. 2002].  
 
 
1.1.2 COMPARATIVE ASPECTS OF REGENERATION 
The evolutionary aspects introduced above raise other interesting questions. There are 
several independent lines of evidence that the organisms, which apparently lost the ability to 
regenerate appendages, like us, still retain some very limited regenerative abilities. Mice 
[TAKEO ET AL. 2013; HAN ET AL. 2008], for instance, and humans [ILLINGWORTH 1974] can 
regenerate distal fingertips, Xenopus laevis tadpoles can completely regenerate limbs, but 
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spontaneously lose this ability upon metamorphosis [YOKOYAMA ET AL. 2001]. Recent 
comparisons of the regenerating mouse digit tip and the axolotl limb regeneration revealed 
that on the molecular level the factors mediating the interaction between the nerve and the 
skin in mouse digit tips are similar to those identified the axolotl limbs [TAKEO ET AL. 2013]. 
The key question is whether we can identify the phases that are similar in regenerative and 
non-regenerative species. Forthermore, can we identify key players that behave differently 
and lead to regeneration in some organisms and to formation of a stump in others? Another 
intriguing question is why do organisms lose the ability to regenerate after a certain 
developmental stage. Xenopus, as mentioned above, or even mammalian embryos are able 
to heal epidermal wounds without scars through early stages of development [MURAWALA ET 
AL. 2012]. These lines of evidence lead to a hypothesis that the regenerative ability is not 
completely lost non-regenerating species, but rather poised for some reason.  
When comparing regenerating and non-regenerating species, a primary difference is the 
speed of initial re-epithelialization of the wound. In regenerating species, such as Mexican 
axolotl or the newt, the wound epidermis covers the wound within 12 to 24h depending on 
the size of the animal. However, the speed of re-epithelialization in mammals is much 
slower.  
Not only does the wound epidermis protect the wound from extracellular environment at 
early stages, it also converts to specialized secretory epithelium that is crucial for 
regeneration. This epithelium called apical ectodermal cap (AEC) closely resembles the 
epithelium of a developing limb bud – epical ectodermal ridge (AER). Both share similar 
morphology and express similar genes [MURAWALA ET AL. 2012]. This can be seen as a 
pleiotropy event. 
Nevertheless, despite of the seemingly close relationship between the AEC and AER, the 
comparison of both types of epithelium on the gene expression level is required. 
Comparing the species as distant as human or mouse and salamander is tempting. Due to 
their large evolutionary distance, it is however difficult to identify the differences 
unambiguously related to regeneration. Comparing different salamander species to each 
other and to Xenopus as the out-group should reduce the number of irrelevant differences. 
Nevertheless, it was recently shown [SANDOVAL-GUZMÁN ET AL. 2013] that the mechanisms 
of regeneration might be completely different even within one clade such as salamanders: 
while in the axolotl muscle cells are regenerated by the proliferation of satellite cells that 
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express PAX71, in contrast, myofibers dedifferentiate and contribute to the regenerate in the 
newt.  
Such fundamental differences in the mechanisms of regeneration between two related 
species might at the first glance be confusing, especially in the light of the hypothesis that 
regeneration is an epiphenomenon of development as stated above. However, despite of 
outward resemblance, these two species are approximately 125 million years apart from 
each other [STEINFARTZ ET AL. 2007]. There are even more differences in the regenerative 
abilities of the axolotl and the newt. For instance, adult newts can regenerate the lens of the 
eye, which axolotls cannot. 
Previously, comparative approaches were limited to grafting and amputation experiments as 
well as to labeling of the cells with a few known molecular markers. Due to important 
advances in both, molecular biological tools and computer science and power over the past 
two decades, it is now possible to investigate the exact molecular mechanisms of a process 
as complex as the regeneration of the entire body appendage that consists of multiple very 
different tissues such as muscles, vasculature, nerve tracks, several subtypes of connective 
tissue, and skin. A microarray time-course [KNAPP ET AL. 2013] can, for instance, provide 
information of how gene expression changes over time in the course of regeneration. 
 
 
1.1.3 GENOMIC ASPECTS OF REGENERATION 
Despite its pivotal role for regeneration research, the genome of the axolotl has not been 
sequenced so far. This is mainly due to its extremely large size, which is estimated to be in 
the range between 21.9 billion and 48 billion base pairs [CAPRIGLIONE ET AL. 1987; CALLAN 
1966; EDSTROM ET AL. 1961].  
It took over a decade and a joint effort of hundreds of scientists at tens of centers all around 
the globe to sequence and assemble the human genome [PHIMISTER ET AL. 2012], which is 
only 1/10 of the size of the axolotl genome. Just a decade later, high throughput sequencing 
platforms collectively referred to as next generation sequencing (NGS) are common in many 
laboratories across the world and large-scale sequencing projects are performed on routine 
basis. 
After the first genomes became available (human [VENTER ET AL. 2001; INTERNATIONAL HUMAN 
GENOME SEQUENCING CONSORTIUM 2004], mouse [MOUSE GENOME SEQUENCING CONSORTIUM 
ET AL. 2002], fruit fly [ADAMS ET AL. 2000], E.coli [BLATTNER ET AL. 1997]), it became apparent 
																																																								
1 Note that in axolotl nomenclature all letters of the protein symbols are in upper-case (e.g. FGF8) and gene 
symbols are italicized with only the first letter in upper-case  (e.g. Fgf8). 
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that the complexity of an organism does not correlate with the size of its genome. Though 
the genome of the axolotl is ten times larger than the human genome, the axolotl is not 
more complex than a human. This is often referred to as C-value paradox [EDDY 2012], 
where C is a measure, in picograms, of DNA contained within a haploid nucleus. This 
apparent paradox was resolved by the discovery that the genomes contain large amounts of 
DNA that are transcribed, but do not code for proteins. The difference in sizes of the human 
and salamander genomes, thus, reflects larger amounts of non-coding DNA, rather than the 
difference in the number of genes. 
As the number of sequenced genomes increased, another phenomenon, termed G-value 
paradox, became apparent: all vertebrates have a roughly constant number of expressed 
genes. Both, the C-value [GREILHUBER ET AL. 2005] and the G-value paradox [TAFT ET AL. 
2007], however, only hold true when looking at the protein-coding genes. If the genome is 
separated into coding and non-coding compartments, then it becomes clear that the non-
coding compartments of the genomes vary greatly in size between different species 
[CAVALIER-SMITH 1985].  
With refined annotation of the sequenced genomes and discovery of numerous types of 
non-coding regulatory elements, the notion that non-coding DNA does not contain any useful 
information has been discarded. In contrast, it is was recently demonstrated that some 
regions of the genome are even necessary for proper positioning of the chromosomes 
towards each other [BELTON ET AL. 2012]. 
Although the current technology gradually reaches the level at which both, the amount of 
material required and the cost are not limiting factors any longer [METZKER 2005; METZKER 
2010], the denovo (lat. from the beginning) assembly, i.e. without any external information 
beyond the raw reads, of a large genome still requires a lot of effort and computational 
power. Large genomes can arise due to a number of factors, including full genome 
duplication as in zebrafish [POSTLETHWAIT ET AL. 2000] or an increased intron length as it 
seems to be the case in the axolotl [SMITH ET AL. 2009]. 
In order to avoid the issues related to full genome sequencing and assembly and yet to 
provide some genomic data, several studies were carried out that only focused on the 
portion of the genome that is expressed in a population of the cells – the transcriptome 
[HABERMANN ET AL. 2004; STEWART ET AL. 2013]. Before the advent of NGS those studies 
included the sequencing data obtained by Sanger sequencing. Even though Sanger 
sequencing offers much better sequence quality, the cost per basepair (bp) still is very high. 
This makes it unfeasible to reach coverage that is sufficient for a denovo assembly of a 
transcriptome. 
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1.2 AXOLOTL REGENERATION 
Axolotls can regenerate a number of tissues and structures such as fore- and hind limbs, 
tails including the spinal cord, and gills. However, some of the structures have been studied 
more extensively than the others.  
Two structures that are studied the best in the field of axolotl regeneration are the forelimb 
and the spinal cord. 
 
 
1.2.1 LIMB REGENERATION 
In the light of pleiotropy one can compare the axolotl limb development with the limb 
regeneration. Compared to the development, where the initial limb field represents a 
relatively small and simple tissue context, the amputated adult limb is a very complex 
structure comprised of a number of different tissues such as bones, dermis and epidermis, 
nerve cells, blood vessels, and muscles. This complex mixture of tissues must be 
orchestrated in a very precise and robust way in order to achieve a perfect replicate of what 
was lost due to the amputation. 
The process of limb regeneration starts with the epithelial cells migrating over the edge of 
the amputation plane and covering the wound. At this stage the axolotl regeneration 
response is similar to the mammalian wound healing response [FERRIS ET AL. 2010; 
MURAWALA ET AL. 2012]. In both responses the migration of the cells requires large-scale 
changes in gene expression to dissolve tight junctions and remodel the extracellular matrix. 
However, the subsequent processes differ in the regenerating and non-regenerating 
species. 
After the wound is properly healed, the wound epidermis proliferates, thickens and converts 
into a signaling secretory epithelium, which is termed apical ectodermal cap [MURAWALA ET 
AL. 2012]. Several factors are thought to contribute to this transition. A contact occurs, for 
instance, between the cells migrating from different regions around the circumference of 
the limb that normally never meet [ITEN ET AL. 1975]. Several other studies prove that the 
nerves (or factors secreted by the nerve) are necessary for regeneration [MULLEN ET AL. 
1996; SATOH ET AL. 2011; KUMAR ET AL. 2007]. Both, the nerve and the contact to the cells 
from different circumferential positions are required for regeneration as demonstrated by the 
accessory limb model proposed by Endo [ENDO ET AL. 2004]. 
Despite of the differences in size and complexity compared to the developing limb bud 
mentioned above, regeneration is initiated by the formation of a relatively small and simple 
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growth zone called blastema at the stump (FIGURE 1.2). The blastema is the name for the 
collection of mesenchymal cells covered by the AEC that resembles the limb bud in terms of 
both, size and activation of the developmental program [NACU ET AL. 2011].  
 
FIGURE 1.2: Blastema formation. Upon amputation a collection of presumably undifferentiated cells 
called blastema is formed at the amputation stump and give rise to the regenerate (modified from 
[POSS 2010]). 
Due to the absence of the basal membrane underneath the AEC, there is constant signaling 
between the mesenchymal cells of the blastema and the AEC, which again shows evidence 
for a developmental program being re-activated. A positive feedback loop of FGF10 and 
FGF8 between the blastema and the AEC, respectively, is re-established [MARTIN ET AL. 
2004; CHRISTENSEN ET AL. 2002; HAN ET AL. 2001]. When supplying exogenous FGF10 to the 
adult Xenopus limbs that normally do not regenerate, the expression of FGF8 can be 
induced [YOKOYAMA ET AL. 2001]. Wnt signaling also seems to play an important role in cell 
proliferation and the morphology of the AEC [KAWAKAMI ET AL. 2006]. 
Although the cells within the blastema are morphologically similar, it was shown that they 
originate from multiple different tissues within the mature limb [CHALKLEY 1954] 
(FIGURE 1.3). 
 
FIGURE 1.3: Blastema composition. Different cell types contribute to the blastema independently 
(image from [NACU ET AL. 2011]). 
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Despite of this apparent similarity, the blastema cells remain restricted to the lineage related 
to their embryonic origin at the neurula stage as was demonstrated by a series of embryonic 
transplantation experiments done by Martin Kragl [KRAGL ET AL. 2009]. For instance, muscle 
cells, which derive from the presomitic mesoderm, are unable to form Schwann cells that 
derive from the neural crest or dermis that derives from the lateral plate mesoderm and vice 
versa (FIGURE 1.4). This again resembles the embryonic development, in which by the time 
the limb bud development occurs, the limb bud itself is composed of progenitors restricted 
to a certain tissue. 
 
FIGURE 1.4: Embryonic transplantations. Different blastema cells are restricted to their embryonic 
origin (modified from [KRAGL ET AL. 2009]). 
One remarkable feature of the axolotl limb regeneration is that only the elements distal to 
the amputation plane are reconstituted. Butler demonstrated this property, termed the rule 
of distal transformation, by creating a limb that was inverted along its proximodistal axis and 
amputated through the upper arm (FIGURE 1.5). Upon regeneration the original lower arm 
regenerated the elbow and the lower arm indicating that the cells are aware of their 
proximodistal position, but not of the proximodistal vector [BUTLER 1955]. Thus, cells 
regenerate structures distal to their proximodistal position at the amputation plane. 
 
FIGURE 1.5: Rule of distal transformation. The cells always regenerate structures distal to their 
proximodistal position at the amputation plane (image from [NACU ET AL. 2011]). 
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1.2.2 SPINAL CORD REGENERATION 
The axolotl tail is a laterally flattened, symmetrical structure with dorsal and ventral fins 
made up by lose connective tissue [FERRETTI 2001]. The musculature is organized in 
segments in myomeres that are located laterally, dorsally and ventrally to the vertebrae. The 
spinal cord surrounded by the vertebral neural arches and the associated sensory ganglia 
occupy the central part of the tail. The spinal cord itself is similar to that of other vertebrates, 
as it contains of grey matter containing the neuronal cell bodies surrounded by the white 
matter containing the axons [ALBORS 2014]. There is, however, a fundamental difference: in 
urodeles most of the cells lining the central canal, called ependymal or ependymoglial cells 
[EGAR ET AL. 1972], have processes that end in expanded end feet at the surface of the pia 
mater (FIGURE 1.6). The morphology of those cells is reminiscent of the radial glia cells that 
are present in the spinal cord in other vertebrates and give rise to both neurons and glia.  
 
FIGURE 1.6: Structure of the urodele spinal cord. The ependymal have processes that end in 
expanded end feet at the surface of the pia mater (image from [FERRETTI 2001]). 
Furthermore, the urodele ependymal cells express keratin 8 and 18, both of which were 
reported to be expressed in the ependymal cells of other regenerating species. Expression 
profiles of those keratins during regeneration resemble those during early neural 
development [WALDER ET AL. 2003].  
Other than in the field of limb regeneration, where the regeneration of a complex tissue 
mixture is investigated, the field of spinal cord regeneration focuses on a single structure. 
Moreover, there are multiple injury paradigms: either spinal cord transection or tail 
amputation. In both cases the injuries to the spinal cord are accompanied by some collateral 
damage. Although axolotls can repair both types of injuries, the mechanisms might be 
different. For instance, the spinal cord transection induces epithelial to mesenchymal 
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transition of the resident spinal cord cells [O'HARA ET AL. 1992], which was not reported after 
tail regeneration [WALDER ET AL. 2003]. 
Similar to the limb regeneration, the first event following the injury is wound closure by the 
epithelial cells. The ependymal cells adjacent to the amputation plane migrate to seal off the 
severed spinal cord and form a terminal vesicle. Just as in the limb regeneration, the wound 
epidermis thickens but does not form the basal membrane in order to allow for signaling 
between the wound epidermis and the mesenchymal blastema cells. The origin of the 
blastema cells in the tail has not been studied as precisely as in the limb, though. 
Regeneration of the spinal cord begins with the migration of the cells from the stump 
towards the terminal vesicle, where they start to divide to form the so-called ependymal 
tube [FERRETTI 2001]. The ependymal tube is a pseudostratified neuroepithelium that 
resembles the neural tube of developing embryos and will give rise to the neurons and glia 
of the regenerated spinal cord. 
In contrast to limb regeneration, the nerve is not enough for successful tail regeneration. 
This was demonstrated by a series of experiments, in which the spinal cord was removed 
and sciatic nerves were deflected into it before amputation. Those tails failed to regenerate. 
Holtzer rotated a piece of the spinal cord dorsoventrally by 180° prior to tail amputation and 
showed that the signals coming from the ventral spinal cord are necessary for the blastema 
cells condensation [HOLTZER 1956]. 
The ependymal cells are multipotent as was demonstrated by a lineage-tracing experiments 
[MCHEDLISHVILI ET AL. 2007], in which single cells were labeled by in vivo electroporation of 
GFP plasmids and subsequently contributed to all dorsoventral regions of the regenerating 
spinal cord. 
 
 
1.3 REGENERATION: BY-PRODUCT OF DEVELOPMENT OR EVOLUTIONARY TRAIT? 
From a comparative biology point of view, the regeneration of the axolotl limb and the spinal 
cord resembles the development in terms of signaling between the specialized epithelia and 
lineage-restricted progenitor cells that drive both processes. There are also different 
environmental and molecular cues that help the cells to orient themselves.  
Recently, two assemblies of the newt transcriptome [ABDULLAYEV ET AL. 2013; LOOSO ET AL. 
2013] were published. With the generation of the axolotl transcriptome described in the next 
chapter, the transcriptomes of two related species with different regenerating potential 
became available. This offers a unique chance to address the question whether regeneration 
is simply a pleiotropic by-product of development and operates on a ubiquitous set of genes 
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that is common to most or all of the vertebrates but is differentially regulated in salamanders 
or whether it is an example of converged evolution and, thus, represents an adaptation trait. 
To date, only the gene Prod1 has been reported to be presumably salamander-specific and 
implicated in regeneration [GARZA-GARCIA ET AL. 2010; DA SILVA ET AL. 2002]. 
In this work I also addressed the question whether there are more salamander-specific 
genes that are involved in both regeneration and development. 
 
 
1.4 AIMS OF THE THESIS  
In this work I aimed to accomplish two goals. My first objective (see Chapter 2) was to 
create a comprehensive transcriptome assembly of the Mexican axolotl, Ambystoma 
mexicanum. To this end I used all previously available sequence data and additionally 
sequenced a substantially broader range of different tissues and organs in order to increase 
the coverage and capture even transcripts expressed at low levels and at a number of 
various developmental and regeneration stages.  
In the second part of my project I aimed to approach the question introduced above whether 
regenerative abilities represent an adaptive trait that regenerating species developed 
independently in the course of evolution, or whether regeneration is not a stand-alone ability, 
but rather a by-product of another more basal process such as embryonic development. 
Two recently published assemblies of the newt, Notophthalmus viridescens, transcriptomes 
[ABDULLAYEV ET AL. 2013] gave me an opportunity to perform interspecific comparisons and 
identify putative salamander-specific transcripts that play a role in regeneration. 
The second goal was, therefore, to study the molecular function of one of the identified 
presumable salamander-specific candidate genes using CRISPR/Cas system.  
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CHAPTER 
2 
 
DE NOVO ASSEMBLY AND ANNOTATION OF THE 
AXOLOTL TRANSCRIPTOME 
 
2.1 INTRODUCTION TO SEQUENCING 
Ever since Watson and Crick proposed the double-stranded helical structure of the DNA 
molecule in 1953 [WATSON ET AL. 1953], scientists aimed for methods to determine the order 
of the four nucleotide bases in that molecule, which served as a blueprint of the organism. 
Knowledge of the DNA sequence became indispensable for many areas of the biological 
research. 
It took over a decade from the initial discovery of the DNA structure to the first experiment 
that determined the sequence of the DNA. There were several intimidating reasons for this 
delay: i) the chemical properties of different DNA molecules were very similar, which made 
it difficult to separate them; ii) the chemical properties of the four bases were far less 
variable than those of the 20 amino acids; iii) the length of naturally occurring DNA 
molecules was much longer than that of proteins, which could already be sequenced at that 
time [EDMAN 1950].  
However, some RNA molecules seemed more suitable for sequencing using methods 
adapted from protein sequencing. In particular, transfer RNAs (tRNAs) are very small and can 
be purified. Consequently, the alanine tRNA from E.coli was the first nucleic acid molecule 
that was sequenced by Holley and colleagues in 1965 [HOLLEY ET AL. 1965] (FIGURE 2.1). 
FIGURE 2.1: Structure of alanine tRNA. The structure of the first sequenced nucleic acid molecule 
(modified from [HOLLEY ET AL. 1965]). 
The discovery of the type II restriction enzymes – i.e. restriction enzymes that cut within or 
at short specific distances from their recognition site – in 1970 [SMITH ET AL. 1970] was a 
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turning event for the field of DNA sequencing, as it allowed to cleave a large DNA molecule 
into a number of small fragments that could be separated by gel electrophoresis. The 
fragments have specific ends that could be used as starting points for the sequencing 
methods. 
	
	
2.1.1 SANGER 
In 1975 Sanger introduced the plus-and-minus method for DNA sequencing [SANGER ET AL. 
1975]. In this method DNA polymerase I [LEHMAN ET AL. 1958] was used to extend the 
primed template using four deoxynucleotide triphosphates (dNTPs), one of which was 
labeled by a radioactive phosphor P32, producing a mixture of DNA molecules of different 
lengths. Afterwards, the mixture was purified from the remaining dNTPs and separated into 
eight equal amounts, which were subjected to another round of polymerization. However, in 
that step the extension reaction was terminated in a sequence-dependent manner by 
providing either three of four dNTPs (minus) or only one (plus). The DNA sequence could be 
determined by separating the eight reactions on a denaturing gel. The method was, 
however, only useful for single-stranded DNA and all eight mixtures had to be used together 
in order to determine the sequence. 
In 1977 Sanger and colleagues proposed a dideoxy method for sequencing that quickly 
replaced the plus-and-minus method and became the most widely used method for DNA 
sequencing for the next 25 years [SANGER ET AL. 1977]. The cornerstone of the method was 
the discovery that 2’,3’-dideoxythymidine-5’-triphosphate (ddTTP) inhibits the activity of the 
DNA polymerase I when it is incorporated into the growing DNA chain [ATKINSON ET AL. 
1969] because ddTTP is missing a 3’-hydroxyl group (FIGURE 2.2) required for 
phosphodiester bond formation between two nucleotides. 
 
FIGURE 2.2: Nucleotide structure. Left panel shows a normal dNTP that is used to extend the DNA 
chain normally. Right panel displays the modified nucleotide. Note the absence of the OH group at the 
3’ position. This makes it impossible to extend the DNA chain beyond the ddNTP (modified from 
[FREEMAN ET AL. 2014]). 
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At the reaction initiation a small complementary piece of DNA called primer is added to the 
DNA fragment to sequence (FIGURE 2.3). In the subsequent steps the DNA polymerase I 
extends the primed strand using the four nucleotides (dATP, dCTP, dGTP, and dTTP) also 
present in the reaction buffer solution. A small fraction of radioactively labeled ddNTPs is 
added to the buffer, thus, causing the extension to terminate at different random positions 
along the DNA molecule. The sequencing reaction is carried out in four separate reaction 
tubes – one per ddNTP. 
Sanger sequencing system in the form as we know it was first described in 1986 [SMITH ET 
AL. 1986]. In contrast to the original method, the four ddNTPs were attached to different 
fluorescent dyes that were used for identifying and discriminating individual ddNTPs. The 
advantage of this change is two-fold – first, no radioactivity is involved and second all 
reactions can be performed in a single tube.  
 
FIGURE 2.3: Sanger sequencing. Left panel: the sequencing reaction is initiated by the addition of 
the complementary primer. In the subsequent steps the DNA is extended by incorporation of the 
dNTPs. Once a modified ddNTP is incorporated the extension reaction is terminated exposing the 
labeled last nucleotide. Right panel: the products are separated by length on a gel and the sequence 
is read from bottom (shorter fragments) to top (longer fragments). 
Since incorporation of the ddNTPs is random, a whole range of products of different lengths 
is present. The reaction products are separated by length on the acrylamide gel after several 
rounds of extension. Due to the fact that the last nucleotide in the extended DNA chain is a 
fluorescently labeled ddNTP, it can be identified when it passes the detector at the end of 
the gel. The entire sequence of the fragment is determined like this.  
A major breakthrough happened in 1996 when Applied Biosystems (ABI) introduced ABI 
PRISM 310 [WATTS ET AL. 2001], in which the gel was replaced by a capillary system. This 
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system was fully automated and made the tedious process of manually pouring the 
acrylamide gels unnecessary, thus, greatly improving the throughput.  
 
 
2.1.2 NEXT-GENERATION SEQUENCING 
Despite of the advances in Sanger sequencing methods the relatively low throughput 
became the limiting factor in the presence of permanently growing demands in sequencing 
output. This triggered the efforts to develop new sequencing methods that would be able to 
sequence multiple samples in parallel, thus, increasing the throughput. High throughput 
sequencing platforms also often referred to as next generation sequencing (NGS) or deep 
sequencing allowed sequencing the same region multiple times, thus, increasing the depth 
of sequencing [METZKER 2010; MARDIS 2008; SHENDURE ET AL. 2008; OZSOLAK ET AL. 2011]. 
While new techniques allow for completing sequencing intentions that would take years 
with Sanger sequencing in just a few weeks, they also generate significantly shorter reads 
with substantially lower accuracy [LIU ET AL. 2012].  
 
 
2.1.2.1 ROCHE/454 
Roche/454 platform [MARGULIES ET AL. 2005] was the first commercially available platform 
that offered high-throughput sequencing. It uses an alternative sequencing technology 
known as pyrosequencing [RONAGHI ET AL. 1998]. 
The system relies on fixing nebulized fragments of target DNA to small capture beads in a 
water-in-oil emulsion. Target DNA molecules are first randomly sheared into small 
fragments. Then adapters are ligated to the ends of the fragments allowing them to attach 
to the surface of the beads. Each individual bead is isolated within an emulsion droplet, 
where the attached fragment is amplified by PCR (FIGURE 2.4a). The purpose of amplification 
is to generate enough material for reliable detection. After amplification individual beads are 
immobilized in separate wells on an optic-fiber slide and the DNA is denatured in order to 
expose single stranded DNA. Afterwards, a mixture of DNA polymerase, ATP sulfurylase 
[BANDURSKI ET AL. 1956], luciferase [GOULD ET AL. 1988], apyrase [SMITH ET AL. 2002], and 
luciferin [HASTINGS 1996] along with the substrate adenosine 5´ phosphosulfate (APS) 
[NEGISHI ET AL. 2001] are added to the reaction buffer (FIGURE 2.4b). Similar to Sanger 
sequencing, DNA polymerase I is used to carry out the primed synthesis reaction. However, 
in contrast to the classical method sequencing relies on the detection of the nucleotide 
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incorporation, rather than chain termination. Therefore, the method is also called sequencing 
by synthesis.  
The nucleotides are added one after another in a predefined order. The incorporation of a 
dNTP into the growing chain releases a pyrophosphate (PPi, hence the name), which is 
converted into ATP by the ATP sulfurylase in the presence of the APS. This ATP further acts 
as a substrate for the luciferase-mediated conversion of luciferin to oxyluciferin [HASTINGS 
1996], which generates visible light that can be detected by the camera and evaluated by 
the computer (FIGURE 2.4b,c). Unincorporated nucleotides and ATP are degraded by the 
apyrase and the reaction is repeated with the next nucleotide. 
 
a. Preparation. DNA template molecules are attached to the beads and amplified by PCR. 
Afterwards, the beads are immobilized on a glass slide. 
 
 
c. Readout. Sample read-out of the method. The intensity 
of the signal is proportional to the number of bases 
incorporated in a single step. 
 
b. Sequencing reaction. Sequencing is 
carried out along with DNA synthesis 
and the incorporation of a base into the 
DNA chain is detected. 
 
FIGURE 2.4: Roche/454 sequencing. Workflow. Each sequencing reaction is carried out in a 
separate well, thus, allowing for high-throughput and parallel sequencing (adapted from [METZKER 
2010]). 
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2.1.2.2 ILLUMINA 
The sequencing begins with fragmentation of the DNA molecules into small fragments 
(usually 200-400bp) followed by the ligation of special adapters to the ends of the fragments 
[BENNETT 2004; BENTLEY ET AL. 2008]. There are small differences in sample preparation for 
DNA and RNA sequencing, which are discussed in more detail below.  
Similar to Roche/454 the target fragment is first amplified by PCR to generate enough 
copies for reliable detection. Solution containing single-stranded DNA with ligated Illumina 
P7 (blue) and P5 (green) adapters is poured onto a slide covered with covalently bound 
oligos, which are complementary to either P5 or P7 (FIGURE 2.5). In the first round the DNA 
molecules bind to the complementary oligos as they flow over the cell. The oligo is 
afterwards extended and generates a complementary copy of the original fragment, which is 
covalently bound to the slide through the oligo. 
 
FIGURE 2.5: Illumina sequencing. Amplification. In the initial step a single-stranded DNA molecule 
binds to the oligo on the surface of the slide. The oligo is extended to form the complementary 
strand. Afterwards the original strand is washed away. The product undergoes several (usually 35) 
rounds of bridge amplification to generate local clusters. 
In the next rounds each covalently bound molecule is used to generate local clusters by a 
process called bridge amplification (FIGURE 2.6a).  
P5 and P7 oligos have incompatible restriction sites. After the bridge amplification the 
primary restriction is performed releasing half of the covalently bound molecules. The other 
half remains attached to the slide by its 5’ end. Therefore, sequencing primers can bind to 
the free 3’ ends and initiate the second strand synthesis. 
Illumina is also a sequencing-by-synthesis platform as the incorporation of a nucleotide is 
detected. In the sequencing steps a mixture of all four fluorescently labeled nucleotides is 
added to the slide  (FIGURE 2.6c). However, since the nucleotides carry a modification at the 
3’ position  (FIGURE 2.6b) no phosphodiester bond can be formed and, therefore, the chain 
extension is stopped. In contrast to Sanger sequencing, this termination is reversible. After 
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the successful incorporation of the nucleotides the slide is imaged and the nucleotides 
incorporated in each cluster are determined based on color of the attached fluorescent dye 
(FIGURE 2.6d). After the imaging step the 3’ block is removed allowing for the next round of 
extension. 
 
 
a. Bridge amplification. First the DNA molecules are 
amplified by PCR to produce local clusters. 
 
 
b. Nucleotide structure. 3’-blocked 
reversible terminator nucleotide. Note 
the fluorophore (arrow) attached to the 
base and the 3’ modification (yellow 
rectangle). 
 
 
c. Readout. The nucleotides incorporated 
in each step can be identified based on 
the color of the attached fluorophore. 
 
c. Sequencing procedure. In each step all four 
nucleotides are added to reaction. Upon incorporation no 
further extension is possible until the slide is imaged and 
the 3’ block is removed. 
 
FIGURE 2.6: Illumina sequencing. Workflow.. Multiple templates can be sequenced simultaneously 
allowing for high-throughput sequencing (adapted from [METZKER 2010]). 
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Since restriction sites within P5 and P7 oligos are different, the same fragment can be 
sequenced from both ends. This so-called paired-end sequencing is widely used for 
assembly, as the approximate fragment length and, thus, the distance between the reads is 
known. After the first round of sequencing the DNA is again denatured and the strand 
generated during the sequencing step is washed away. The remaining strand undergoes 
another round of bridge amplification. Finally, secondary restriction is performed and the 
strands released by the restriction are washed away. The remaining strands represent 
another ends of the same fragments and are sequenced in the same fashion as the first 
strand.  
There are some mild variations in how DNA and RNA libraries are prepared for sequencing. 
While in case of DNA template the molecules are simply sheared into fragments as 
described above, in case of mRNA template an intermediate cDNA molecule is required, 
since Illumina sequencing method cannot sequence RNA directly. The mRNA can be reverse 
transcribed into the cDNA either using poly-dT-primers or using the random hexamer 
primers. In case of poly-dT-priming the resulting cDNA fragments are biased towards the 3’ 
end of the original mRNA, while when random hexamers are used the coverage is more 
uniform (FIGURE 2.7) [WANG ET AL. 2009].  
 
FIGURE 2.7: Illumina sequencing. Library preparation. RNA fragmentation prior to sequencing 
yields a more uniform coverage of the transcript, while cDNA fragments are biased towards the 3’ 
end of the template (modified from [WANG ET AL. 2009]). 
The choice of the method depends on the task. In this study the mRNA from all samples has 
been transcribed into cDNA using random hexamers first as I wanted to get a uniform 
coverage over the entire length of the transcripts. 
 
	 23	
2.1.2.3 PACIFIC BIOSCIENCES 
The last sequencing method used in this study is Pacific Biosciences (PacBio). The 
advantage of this method is the absence of the DNA amplification step as the method is a 
single molecule real time sequencing method.  
The key feature is the optical zero-mode waveguide (ZMW) [LEVENE ET AL. 2003], which 
guides light energy into a volume that comparable to the wavelength of the light in all 
dimensions. A single DNA polymerase molecule is immobilized at the bottom of the ZMW 
with a single DNA molecule template. The ZWM is small enough to allow for detection of a 
single nucleotide being incorporated into the DNA chain. Each of the four nucleotides is 
attached to a fluorophore, which is cleaved off after the nucleotide is successfully 
incorporated and diffuses out of the observation area. The base calls are made based on the 
color of the fluorophore (FIGURE 2.8). 
FIGURE 2.8: PacBio sequencing. Workflow. Other than in other techniques, no amplification step is 
required (adapted from [METZKER 2010]). 
Due to the fact that PacBio relies on incorporation detection it is prone to sequencing 
mistakes especially if an incorrect nucleotide is incorporated and afterwards removed by the 
3’→5’ exonuclease activity. In order to overcome this problem the circular consensus 
protocol was developed (FIGURE 2.9). In this protocol the same fragment is sequenced 
multiple times and the subreads are aligned afterwards. Since the subreads originate from 
the same template it is trivial to align them and to build a high-confidence consensus 
sequence. 
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FIGURE 2.9: PacBio sequencing. Circular consensus protocol. Multiple subreads from the same 
template are aligned and the consensus sequence is derived (image from PacBio SMRT portal help 
page 
[http://files.pacb.com/software/smrtanalysis/2.2.0/doc/smrtportal/help/!SSL!/Webhelp/Portal_PacBio_
Glossary.htm]). 
 
 
2.1.3 SEQUENCE ASSEMBLY 
Historically, a small number of genetic markers were employed to study the gene content of 
an organism, tissue or cell and their relevance for diverse cellular processes. Advances in 
sequencing technologies over the past several decades initiated the transition to high 
throughput sequencing in 1991 [ADAMS ET AL. 1991]. Initially, due to technical limitations of 
the DNA chain termination technique, the sequencing efforts were mainly focused on 
relatively short complementary DNAs (cDNAs), termed expressed sequence tags (EST) 
[ADAMS ET AL. 1991], in order to refer to this new type of sequence information. Since the 
ESTs represent sequences originating from a particular organ or structure, the collections 
thereof gave a first approximation of the diversity of the expressed genes in that tissue or 
structure [CHRISTOFFELS ET AL. 2001]. However, the many ESTs simply represent fragmented 
disjoint pieces of transcripts. 
Rapid advances in sequencing technologies and bioinformatics have initiated the transition 
from sequencing of the individual sets of ESTs to sequencing of the whole transcriptomes 
and genomes. Not only did the ambitious sequencing projects like the human genome 
project generate an overwhelming amount of data [VENTER ET AL. 2001; INTERNATIONAL 
HUMAN GENOME SEQUENCING CONSORTIUM 2004], but they also gave an impulse to the 
development of both, the experimental methods to preprocess ESTs to avoid unnecessary 
sequencing and to the computational methods for the sequence assembly.  
Moreover, the large drop in the cost and the notably increased throughput of the sequencing 
technologies over the past decade motivated the assembly of transcriptomes of several non-
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model organisms including but not limited to turtles [TZIKA ET AL. 2011], chickpea [GARG ET 
AL. 2011] and planarians [LIU ET AL. 2013; ADAMIDI ET AL. 2011]. 
An efficient assembly requires sufficient amounts of high quality sequencing data. The data, 
in turn, must represent the whole range of sequences of the sample. While it is relatively 
easy and uncomplicated to collect enough sequencing data to cover the genome, it 
becomes substantially more complicated when it comes to capturing the whole diversity of 
different transcripts in different cell types and organs and at different developmental stages.  
In a eukaryotic cell the number of transcripts of different genes varies greatly from as few as 
several copies to several thousand copies. High abundance transcripts of as few as only 5-
10 genes account for approximately 20% of the cellular mRNA. The intermediate abundance 
transcripts of 500-2000 genes account for another 40-60% of the mRNA. The remaining 20-
40% are rare transcripts that are likely to be cell type or tissue-specific [ALBERTS ET AL. 2002]. 
Such variation would result in recurrent sequencing of the same more abundant transcripts 
at the expense of the rare transcripts.  
The cDNA normalization method [BOGDANOVA ET AL. 2010; ZHULIDOV ET AL. 2005; ZHULIDOV ET 
AL. 2004; BOGDANOVA ET AL. 2008] is used to decrease the variation and equalize the 
concentrations of different transcripts in the sample. In brief, the sample is first denatured 
and then allowed to re-nature again. The more abundant transcripts re-anneal more 
efficiently, thus, forming double-stranded cDNA, which is digested by the duplex-specific 
nuclease (DSN) [SHAGIN ET AL. 2002]. The remaining single-stranded DNA is amplified under 
the conditions that do not favor the amplification of shorter fragments at the expense of the 
longer and used for library creation. 
Assembly algorithms are required to process rapidly growing datasets effectively and to 
avoid misassemblies due to redundant sequences and repetitive regions. Proper assembly 
of multiple individual sequence reads in the absence of the reference sequence poses, 
therefore, the most challenging task for any de novo assembly of either a genome or a 
transcriptome.  
Back in the early 2000’s when the human genome project was first initiated, the only 
available sequencing technology was Sanger. It produced a fairly low amount of relatively 
long (up to 1kb) high quality reads. The assembly of such sequence reads is straightforward 
and is referred to as the overlap layout consensus alignment [PELTOLA ET AL. 1984; EDWARDS 
ET AL. 2009]. However, recent advances in sequencing technologies made this approach 
impractical as modern platforms produce hundreds of millions of short and relatively low 
quality reads. The problem of assembling short reads with sequencing errors can be 
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approached using a so-called De Bruijn graph [BORDZILOVSKAYA ET AL. 1989; BRUIJN 1946; LI 
ET AL. 2012].  
 
 
2.1.3.1 OVERLAP LAYOUT CONSENSUS 
The basic algorithm consists of three major steps: i) overlap, ii) layout, and iii) consensus, 
hence the name (OLC). As the name implies, in the overlap step all pairwise comparisons 
between the sequence reads in both forward and reverse orientations are carried out in 
order to build an overlap graph (FIGURE 2.9) that later can be traversed to generate the 
consensus sequence. Different algorithms employ different criteria for overlap identification. 
The latter differ in the overlap length as well as in the required similarity between the 
sequences.  
The assembly algorithms must recognize and remove redundant branches from the graph. 
For instance, in FIGURE 2.10 the node R3 can be removed without affecting the overlaps 
because R2 directly overlaps with R4 and R5. While some overlaps are redundant, others 
represent false overlaps between the homologous regions of distant sequences and cannot 
always be identified reliably (see 2.1.3.3 Caveats).  
 
FIGURE 2.10: Overlap layout consensus. a. Set of overlapping reads (overlaps shown in different 
colors). b. Overlap graph that represents all overlaps between the reads. Note that the overlaps 
between the reads R3, R4 and R5 generate branches in the graph, which must be resolved later. 
One can easily imagine that even in a dataset of a moderate size the resulting overlap graph 
is huge. In order to simplify the graph, in the layout step the reads that clearly overlap and 
belong to the same sequence are compressed into what is referred to as contig, which is 
short for contigous sequence. Once such contigs are identified they are compressed into a 
single node of the graph. 
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In the final consensus step the algorithm traverses the remaining graph and rebuilds the 
underlying consensus sequences. 
 
 
2.1.3.2 DE BRUIJN GRAPH 
It is apparent that with the growing dataset size and decreasing read length the overlap 
layout consensus approach becomes computationally very intense and, thus, impractical for 
real applications. Moreover, the current sequencing platforms have significantly higher error 
rate compared to that of the Sanger sequencing. These sequencing mistakes would 
additionally complicate the graph. In order to overcome the problem of pairwise 
comparisons a somewhat counter-intuitive approach called De Bruijn graph (FIGURE 2.11) 
was proposed by Pevzner and colleagues in 2001 [PEVZNER ET AL. 2001]. In order to build this 
graph the reads are broken into even smaller overlapping fragments termed k-mers, where k 
defines the length of such fragments.  
 
a. Set of short reads 
 
b. k-mers. All possible k-mers for k=5 
 
c. Graph. Resulting De Bruijn graph 
FIGURE 2.11: De Bruijn graph. a. Set of NGS reads. b. After breaking the reads into a set of k-mers, 
the algorithm starts at any node (1) and connects it to the node it overlaps with by k-1 bases (2). The 
graph is further processed in the same manner through the nodes (3), (4) and so on until all nodes 
have been incorporated into the graph. c. De Bruijn graph based on the k-mers from b. One can 
already see the edge between the nodes GTTTT and TTTTC (red arrowhead), which is not supported 
by any read and, thus, represents a false overlap. 
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At the beginning all k-mers represent disjoined nodes with the list of reads that contain this 
particular k-mer attached to each node. In the subsequent steps nodes that overlap by k-1 
bases are connected by an edge.  
Since the k-mers are even shorter than the original reads the likelihood of the false overlaps 
is high. In order to simplify the graph and remove the false edges, different assembly 
algorithms employ slightly different approaches, which nevertheless can be brought to the 
same basic principles. First, the original reads are mapped to the graph and the edges that 
are not supported by the minimal required number of reads are removed. Moreover, Illumina 
paired-end sequencing information is also used, since the distance between two reads 
originating from the same fragment is known. Therefore, both reads – referred to as left and 
right – are required to be located within a certain length range within the graph. 
Since the k-mers are considerable shorter than the ESTs, de Bruijn graphs are even more 
prone to generating false overlaps in the homologous regions that are longer than the k-
mers.  
 
 
2.1.3.3 CAVEATS 
In the ideal world the sequence to assemble is free of repeats and each region is unique and 
only appears once. However, in the real world the sequences may contain repeats or 
homologous regions (FIGURE 2.12), which make the reliable discrimination of true and false 
overlaps difficult. 
 
a. True overlap. Both reads originate from the same locus within the genome. 
 
b. Repeat overlap. The reads originate from two separate loci that both have a repeat. 
FIGURE 2.12: Read overlaps. Reads R1 and R2 overlap. The dashed line represents the underlying 
true sequence. The orange bar represents the overlapping sequence in both the reads and in the 
underlying sequence. 
 
Since false overlaps are built between distant, e.g. within one chromosome, or even 
unrelated, e.g. between chromosomes or transcripts, sequences, they lead to the formation 
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of chimeras, which are erroneous contigs assembled from two separate sequences that 
share a certain region, a pair of paralogous transcripts sharing a conserved functional 
domain, for instance. 
The problem with the false overlaps can only be solved if the reads that span the repetitive 
or homologous region are available. In this case the overlaps that are not supported by any 
read are removed from the graph. This step is termed error-pruning and is applied to correct 
both OLC and de Bruijn graphs in the course of assembly. However, some false overlaps 
that result from long repeats [JURKA 1998] in the genome or highly conserved functional 
domains in the transcriptome can only be resolved if the reads longer than the respective 
repetitive or homologous regions are available. 
 
 
2.1.4 DATA PREPROCESSING 
While the Sanger sequencing and the NGS platforms differ dramatically in the numbers of 
reads they produce, both can generate reads with low base calling quality or low sequence 
complexity, e.g. long stretches of identical bases. Moreover, each sequencing method 
generates reads that contain contaminating sequences, be it vector remnants or adapter 
sequences for Sanger and NGS platforms, respectively. 
Irrespective of the kind of impurities, it is impractical to use the respective reads for a de 
novo assembly project. Therefore, the reads must be filtered before they can be used. The 
most straightforward filter is the quality filter that trims the reads starting from the position 
at which the base calling score drops under a certain threshold. 
If the variability of the fragments is low, then the sequencing dataset contains many 
redundant reads that increase the size of the dataset, but not the diversity of the sequences 
it contains. To this end, identical reads must be removed in order to reduce the complexity 
of the dataset. 
Depending on the library preparation, sequencing method and the selected fragment size 
occasionally the sequencer reads through the NGS adapter or vector backbone. This 
introduces sequences that did not exist in the original sample. Therefore, it is important to 
remove or trim any reads that contain adapter, primer or vector sequences. 
While the reads representing low complexity regions may have high base calling scores and 
be free of any contaminating sequences, they, nevertheless, challenge the assembler 
algorithm as they facilitate chimera formation. In order to avoid assembly mistakes related to 
misalignments, it is advisable to remove repetitive and low complexity reads from the 
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dataset. In case of a de novo assembly it is better to have a somewhat fragmented 
assembly, rather than to generate multiple chimeric sequences. 
Finally, since NGS platforms generate multiple reads that cover the same region, it is 
possible to identify the reads that are likely to contain sequencing mistakes. Since the 
fragmentation step generates unbiased fragments, one can generate a set of overlapping k-
mers for each read in the dataset, sort them by the frequency and remove the reads that 
contain k-mers that only appear once because they are likely to contain sequencing 
mistakes. 
	 	
	 31	
2.2 MATERIALS AND METHODS 
2.2.1 TISSUE SAMPLES AND DATA 
Unlike the genome that is almost [GOTTLIEB ET AL. 2009] the same in all cells of the body, the 
transcriptome that is a set of all RNA molecules including the messenger RNA (mRNA), 
ribosomal RNA (rRNA) and other non-coding types of RNAs varies depending on the 
particular tissue or cell type. Therefore, in order to capture as many different transcripts and, 
thus, to create as complete transcriptome as possible, I sequenced a number of tissues at 
different developmental stages [BORDZILOVSKAYA ET AL. 1989] using the Illumina sequencing 
technology. I combined the Illumina data with several datasets that were available from the 
previous transcriptome sequencing and assembly projects. Those represented a collection 
of ESTs from two different tissue types – the neural tube (NT) and the regenerating spinal 
cord (6dpaTBL) [HABERMANN ET AL. 2004] – and a collection of Roche/454 reads (TLUAMEX) 
from multiple different tissues [STEWART ET AL. 2013].  
Since the rRNAs comprise the majority (80%-90%) of the transcribed RNA, it is important to 
either deplete [O'NEIL ET AL. 2013] the samples of the rRNAs or to selectively capture the 
mRNAs using the fact that the most mRNAs are polyadenylated, meaning that stretches of 
adenine bases are attached to their 3’ ends. However, a few mRNAs have very short 
polyadenylation tails (polyA-tails) [RICHTER 1999] and some eukaryotic non-coding RNAs have 
poly-A-tails [ANDERSON 2005]. Therefore, while one can enrich the sample for the mRNAs, it 
will never be free of the non-coding RNAs. 
All samples are listed in TABLE 2.1. The samples provided by colleagues in the lab are 
labeled accordingly. All Illumina samples were enriched for the mRNA prior to sequencing. 
 Abbreviation Platform Tissue / Sample Author 
 
0hpiBr Illumina 0 hours post injury brain sample 
Walter Bonacci 
3hpiBr Illumina 3 hours post injury brain sample 
6hpiBr Illumina 6 hours post injury brain sample 
24hpiBr Illumina 24 hours post injury brain sample 
 
nCC Illumina New fibroblast cell culture 
Josh Currie 
oCC Illumina Old fibroblast cell culture 
 E11 Illumina Developmental stage 11  
E19 Illumina Developmental stage 19  
LB Illumina Early limb bud  
TB Illumina Tail bud  
NT Sanger Neural tube Akira Tazaki 
 6dpaTBL Sanger 6 days post amputation tail blastema Akira Tazaki 
8dpaTBL Illumina 8 days post amputation tail blastema  
9dpaLBL Illumina 9 days post amputation limb blastema 
Elena Gromberg 
15dpaLBL Illumina 15 days post amputation limb blastema 
1dpiSC Illumina 1 day post injury spinal cord  
6dpiSC Illumina 6 days post injury spinal cord Akira Tazaki 
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 blHead Illumina Mature head without the brain  
mHeart Illumina Mature heart  
mLiver Illumina Mature liver  
mLungs Illumina Mature lungs  
mSpleen Illumina Mature spleen  
mTestis Illumina Mature testis  
metBrain Illumina Brain of a metamorphosed axolotl  
mSC Illumina Mature spinal cord Akira Tazaki 
 TLUAMEX Roche/454 Axolotl tissue mix Elly Tanaka 
TLLI PacBio Long-insert library  
TABLE 2.1: List of datasets used in this work. The datasets are separated into several different 
groups highlighted using different shading. n brain, n cell culture, n embryonic tissues, n 
regeneration, n mature tissues, n mixed tissues.  
 
 
2.2.2 NT AND 6DPATBL LIBRARIES 
The neural tube (NT) and the 6 days post amputation tail blastema (6dpaTBL) libraries were 
the first sequenced axolotl cDNA libraries in our lab. The former was derived from the dorsal 
regions of stage 18-22 embryos [BORDZILOVSKAYA ET AL. 1989] that contained the neural 
tube, somite and notochord. The latter, as the name suggests, was derived from the 
regenerating tail blastema.  
The mRNA from the samples was reverse transcribed into the cDNA using a poly-dT-primer 
complementary to the poly-A-tail and containing a NotI restriction site. The cDNA was 
afterwards cut using restriction enzyme NotI and ligated into a pCMV SPORT6 vector that 
was linearized with restriction enzymes EcoRV and NotI prior to ligation. This way the 
orientation of the insert was known and it was sequenced using the SP6 primer, therefore, 
all reads in those libraries represent 5’ reads of the inserts (FIGURE 2.13). However, since the 
mRNA was reverse transcribed using a poly-dT-primer, the inserts are biased towards the 3’ 
end of the transcript and do not necessarily represent full-length transcripts. 
 
FIGURE 2.13: Structure of pCMV SPORT6 vector. The cDNA was inserted between NotI and EcoRV 
restriction sites (highlighted in gray) and sequenced using the SP6 primer. 
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While both libraries were very small compared to Illumina libraries, they represented a set of 
unassembled and long high-quality reads that could be used as scaffold to join fragments of 
the same transcript. 
 
 
2.2.3 MIXED-TISSUE ROCHE/454 LIBRARY (TLUAMEX) 
A number of mixed axolotl tissues were sequenced using Roche/454 platform that 
generated 7,047,590 sequences with the average length of 100bp. Despite the shorter 
length, the advantage of this library was the significantly greater number of reads compared 
to the NT/6dpaTBL libraries and a significantly higher coverage of a broader range of 
different transcripts and tissue types. 
 
 
2.2.4 ILLUMINA LIBRARIES 
The majority of the tissues were sequenced using two successive generations of the 
Illumina platform, because this technology is currently the best in terms of cost-performance 
radio. Since the Illumina reads are rather short, all fragments were sequenced in paired-end 
mode in order to make use of fragment size information (see 2.1.2.2 Illumina). 
First, the total RNA was isolated from a sample. mRNA enrichment was carried out using 
1µg of total RNA and the NEBNext Poly(A) mRNA Magnetic Isolation Module (New England 
BioLabs, NEB) according to the manufacturer instructions. After elution in 15µl 2x first strand 
cDNA synthesis buffer (NEBnext, NEB) RNA was chemically fragmented by incubating for 
15 min at 94°C. Afterwards, the RNA sample was immediately subjected to the strand 
specific RNA-Seq library preparation (Ultra Directional RNA Library Prep, NEB) using custom 
ligation adaptors (TABLE 2.2): 
Name Sequence 
Adaptor-Oligo 1 5'-ACA-CTC-TTT-CCC-TAC-ACG-ACG-CTC-TTC-CGA-TCT-3' 
Adaptor-Oligo 2 5'-p-GAT-CGG-AAG-AGC-ACA-CGT-CTG-AAC-TCC-AGT-CAC-3' 
TABLE 2.2: Custom ligation adaptors. Note the phosphotylated 5’-end of adaptor-oligo 2. 
After the ligation the adapters were depleted by SpriBead bead purification (Beckman 
Coulter). Indexing was done in the following PCR enrichment (15 cycles) using custom 
amplification primers (TABLE 2.3) carrying the index sequence indicated by ‘NNNNNN’.  
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Primer Sequence 
Primer 1 5'- AAT-GAT-ACG-GCG-ACC-ACC-GAG-ATC-TAC-ACT-CTT-TCC-CTA-CAC-GAC-
GCT-CTT-CCG-ATC-T -3' 
Primer 2 5'- GTG-ACT-GGA-GTT-CAG-ACG-TGT-GCT-CTT-CCG-ATC-T -3' 
Primer 3 5'- CAA-GCA-GAA-GAC-GGC-ATA-CGA-GAT-NNNNNN-GTG-ACT-GGA-GTT-3' 
TABLE 2.3: Custom amplification primers. Note the hexamer in primer 3 indicating the sequence 
index. 
After SpriBead purification (1:1) the libraries were run on the 1,5% Agarose gel (E-Gel, 
Invitrogen) to select for fragments in the range of 200-300 bp. The DNA was eluted using 
the QIAquick gel extraction Kit (Qiagen) and quantified with Qubit dsDNA HS Assay Kit 
(Invitrogen). For Illumina flowcell production samples were equimolarly pooled and 
distributed on all lanes used for 100 bp or 76bp strand-specific paired-end sequencing on 
Illumina HiSeq 2500 or Illumina HiSeq 2000, respectively (TABLE 2.4). 
Sample Platform Read length Reads count 
0hpiBr HiSeq 2500 100 37,009,380 
3hpiBr HiSeq 2500 100 33,465,603 
6hpiBr HiSeq 2500 100 35,524,329 
24hpiBr HiSeq 2500 100 39,915,118 
nCC HiSeq 2500 100 52,558,301 
oCC HiSeq 2500 100 78,237,658 
E11 HiSeq 2500 100 49,202,153 
E19 HiSeq 2500 100 42,195,618 
LB HiSeq 2500 100 31,960,021 
TB HiSeq 2500 100 48,249,280 
8dpaTBL HiSeq 2500 100 38,684,893 
9dpaLBL HiSeq 2500 100 48,976,452 
15dpaLBL HiSeq 2500 100 44,918,070 
1dpiSC HiSeq 2500 100 38,156,994 
6dpiSC HiSeq 2000 76 78,459,950 
blHead HiSeq 2500 100 48,678,117 
mHeart HiSeq 2500 100 51,566,899 
mLiver HiSeq 2500 100 46,417,978 
mLungs HiSeq 2500 100 42,173,168 
mSpleen HiSeq 2500 100 45,638,619 
mTestis HiSeq 2500 100 70,890,460 
metBrain HiSeq 2500 100 42,173,168 
mSC HiSeq 2000 76 65,753,941 
TABLE 2.4: List of Illumina datasets. Two datasets were sequenced using a previous version of 
Illumina hardware and are shaded in gray. 
The common method for the sequencing library preparation does not preserve information 
about the strand a particular read originates from. However, this information may be very 
useful for subsequent analyses. One important aspect is that this information can be used to 
identify overlapping transcripts that are erroneously assembled. In this work I used a method 
commonly referred to as dUTP [BORODINA ET AL. 2011; PARKHOMCHUK ET AL. 2009]. In this 
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method dTTPs are replaced by dUTPs (uracil) when synthesizing the second cDNA strand, 
which later is selectively degraded by uracil-DNA-glycosylase. This only leaves the first 
strand, which has the opposite orientation to that of the original mRNA. This property of the 
strand-specific library was used later to determine the proper orientation of the assembled 
contigs (see 2.3.1 Assembly). 
 
 
2.2.5 LONG INSERT LIBRARIES (TLLI) 
In addition to the NT and 6dpaTBL libraries, I also used seven so called long insert cDNA 
libraries. The size of the insert was substantially larger than that of the Sanger libraries and 
was in the range between 2kb and 10 kb. Each library was a separate 96-well plate with 
about 200 different clones in each well. Thus, ideally a full library contained approximately 
19,200 different inserts. A big advantage of the long insert libraries was that the transcripts 
were normalized (see 2.1.3 Sequence Assembly) and, thus, were not biased towards highly 
abundant transcripts. 
The inserts were located between the SP6 and T7 loci in a pExpress vector and were 
amplified by PCR using SP6 and T7 primers. In order to preserve the normalization as much 
as possible only 20 PCR cycles were carried out. Each 96-well plate was afterwards 
subdivided into two pools of 48 wells each, which were sequenced separately using the 
PacBio circular consensus sequence protocol (see 2.1.2.3 Pacific Biosciences) in order to 
reduce the error rate. The raw reads were afterwards processed using the PacBio SMRT 
portal software, which generated a set of high-quality reads with a mean length of 2.7Kb. 
Similar to the Sanger libraries the long insert library reads also represented a set of long 
unassembled reads. 
 
 
2.2.6 RNA ISOLATION 
Total RNA was isolated using TRIzol according to the instructions of the manufacturer 
(Invitrogen) from all but the cell culture and limb blastema samples, for which I used the 
Qiagen kit, due to very limited amount of starting material. The RNA quality was afterwards 
assessed using Agilent BioAnalyzer requiring the RNA integrity number (RIN) [SCHROEDER ET 
AL. 2006] to be 8 or higher.  
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2.2.7 FILTERING 
All current deep sequencing platforms suffer from a fundamental limitation that is a relatively 
high frequency of the incorrectly read bases. Such errors can be introduced during the library 
preparation step as well as during the sequencing process. In order to tell apart the 
sequencing mistakes from the real biological variation, all sequencers produce quality score 
data, referred to as the Phred score. This score is complementary to the base calling data, 
i.e. sequence files [EWING ET AL. 1998]. The quality score Q of any particular base within the 
sequence is defined as the logarithm of the probability P of the base calling error. In other 
words, the higher is the score the higher is the probability that the base is correct. 
𝑄 = −10 log)* 𝑃 
Irrespective of the further intensions, low-quality reads must be either removed completely 
or trimmed such that only the high-quality portion of a read remains in the dataset.  
In this work I used a very strict quality threshold that required the reads to have the Phred 
score of greater than or equal to 30 over at least 70% of the read length. Additionally, I also 
excluded the low complexity reads using the DUST filter [MORGULIS ET AL. 2006] and 
homopolymers using a software tool I developed for this purpose. In the second step I used 
the FastX toolkit [http://hannonlab.cshl.edu/fastx_toolkit] to collapse duplicated reads into a 
single read, since they do not contribute any new data. Note that in order to preserve paired-
end information, entire pair was removed if one of the reads did not pass the filters.  
 
2.2.8 TRANSCRIPTOME ASSEMBLY 
Due to the variability of the datasets in terms of both read count and the sequencing 
platform used, there were two ways to assemble the data: i) the data could either be 
assembled together using a single assembly program or ii) different datasets could be 
assembled independently using appropriate software, merging the assemblies in a 
subsequent step. 
Since the majority of the sequence reads were short Illumina reads, I first tried to assemble 
all datasets – Illumina, Roche/454, PacBio, and Sanger sequences – simultaneously using 
Velvet/Oasis [SCHULZ ET AL. 2012] and Trinity [GRABHERR ET AL. 2011], which both are 
designed to assemble short reads. To this end I generated short artificial Illumina-like reads 
from the long sequences in order to make the datasets comparable in terms of read counts 
(FIGURE 2.14).  
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FIGURE 2.14: Combined data assembly approach. Short artificial Illumina-like reads (blue-yellow for 
forward and reverse reads, respectively) were generated from the long reads and pooled together 
with the real Illumina reads (green-red for forward and reverse reads, respectively) for the subsequent 
assembly.  
However, Velvet/Oasis turned out to be more suitable for genome rather than transcriptome 
assembly and, thus, generated a more fragmented assembly comprised of multiple short 
(200-300bp) contigs. One potential reason for that could be different splice variants present 
in the transcriptome but not the genome. Therefore, subsequently I decided to use Trinity 
(r20140717), which was designed to assemble transcriptomes and can handle the presence 
of splice variants correctly. 
There were, however, two major objections to using this approach. Imagine a long sequence 
that either contains a sequencing mistake, or represents contamination, or even is a 
chimeric erroneous sequence. Due to its low frequency, it would fail to generate an overlap 
with any other sequence and will not be included into the assembly when using an OLC 
assembler. However, generating artificial reads increases the frequency of erroneous reads 
in the sample, thus, increasing the likelihood of misassemblies with other short reads. 
Another objection was that long sequences represent stretches of unassembled sequences, 
whereas this information had been lost when short artificial reads were generated. 
In order not to lose any bit of information provided by the data, I decided to preprocess (see 
2.2.7 Filtering) and assemble the datasets independently (FIGURE 2.15). Both partial 
assemblies were analyzed for evidence for bacterial, viral or any other contamination (see 
2.2.9 Potential Contamination). Examples thereof are artemia and artificial vectors. 
Subsequently the partial assemblies were merged using the overlap layout consensus 
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algorithm. In the final step contigs were verified using genomic data (see 2.2.11 Genomic 
Data) and annotated (see 2.2.10 Annotation and ORF Prediction) 
 
FIGURE 2.15: Transcriptome assembly pipeline. The data from the different sequencing platforms 
were initially processed and pre-assembled independently. Afterwards, the assembled sequences 
were combined, filtered for sequence of non-axolotl origin and re-assembled. PacBio data were used 
to verify contigs, but not for the assembly. Finally, the assembly was annotated, protein domains 
were identified, and ORFs were predicted. 
 
 
2.2.9 POTENTIAL CONTAMINATION 
Since the tissues used in this study included non-sterile tissues, e.g. full embryos or 
blastemas, as well as the animals with genetically modified background, e.g. GFP animals 
[SOBKOW ET AL. 2006], the likelihood of sample contamination was relatively high. 
In order to remove any contigs of non-axolotl origin, the assembly was blasted against the 
NCBI non-redundant nucleotide database (nr) and the UniVec database 
(http://www.ncbi.nlm.nih.gov/tools/vecscreen/univec/) using blastn [ALTSCHUL ET AL. 1990]. 
The contigs with similarity of 85% or higher to the potential contaminants (FIGURE 2.16) 
were labeled as such and removed from subsequent analyses. 
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FIGURE 2.16: Contamination example. The query contig matches the cloning vector. 
 
 
2.2.10 FUNCTIONAL ANNOTATION AND ORF PREDICTION 
Associating individual transcripts with biological functions is the most important task in de 
novo transcriptome annotation. Functional annotation allows for better understanding of 
biological processes in which the putative proteins are involved as well as for inferring their 
presumable function. For non-model organisms the usual way is to blast the contigs against 
the database of known proteins, e.g. NCBI non-redundant database, and assign the 
annotation based on similarity. Existing software packages, e.g. Blast2GO [CONESA ET AL. 
2005], are based on this principle. However, Blast2GO was far to slow for my purposes as it 
uploads the sequences to the Blast servers. Instead, I developed my own annotation script 
that downloaded the recent release of the RefSeq database and performed the annotated 
locally.  
 
 
2.2.10.1 ANNOTATION USING HOMOLOGS 
The reference sequence project database (RefSeq) [PRUITT ET AL. 2003] provides an 
integrated, non-redundant, and well-annotated set sequences. It includes both DNA and 
protein sequences information of seven organisms and is updated on a weekly basis. Data 
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of seven organisms – human, mouse, rat, cow, pig, zebrafish and frog – are curated 
manually. I set up a pipeline that automatically downloaded the latest RefSeq release and re-
annotated the transcriptome assembly. To this end only protein sequences were 
downloaded, since protein sequences evolve much slower than their respective DNA 
sequences. The proteins were blasted (tblastn) against the transcriptome assembly and the 
annotation, i.e. gene name and definition, was copied from the best hit. 
The blast hits were separated into four categories based on the e-value: i) strong homologs 
(e-value <1e-90); ii) putative homologs (e-value 1e-50 – 1e-90); similar (e-value 1e-20 – 1e-
50); weak homologs (e-value 1e-5 – 1e-20). 
 
 
2.2.10.2 ANNOTATION USING CONSERVED PROTEIN DOMAINS 
I also predicted protein domains using the latest release of InterProScan [ZDOBNOV ET AL. 
2001] (http://www.ebi.ac.uk/Tools/pfa/iprscan5/). Annotated and non-annotated contigs were 
treated differently. While the putative ORF of the annotated contigs was known and given 
by the annotation, all possible ORFs longer than 300bp of the non-annotated contigs were 
subjected to the protein domain prediction algorithm. 
This helped to infer function of some contigs that did not have any RefSeq homologs. 
 
 
2.2.10.3 PREDICTION OF OPEN READING FRAMES 
Similar to protein domain prediction, open reading frames (ORFs) prediction differed for 
annotated and non-annotated contigs: i) for contigs with RefSeq homologs the aligned 
portion of the sequence was extended to the left until the left-most in-frame ATG was 
encountered or the beginning of the contig was reached and to the right until the first in-
frame terminal codon was encountered (FIGURE 2.17); ii) for contigs without homologs all 6 
frames have been translated and the longest ORF that had both the initial start and a proper 
terminal codon was kept. However, if a non-annotated contig had an annotated protein 
domain, the ORF containing that domain was used irrespective of the length of that ORF. 
 
FIGURE 2.17: ORF prediction. The aligned homologous region of the contig (top sequence) is 
extended to the left until the left-most methionine (green arrowhead) and to the right until the first 
terminal codon (red arrowhead). 
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Based on whether the ORF had the start codon and a proper terminal codon, I defined four 
classes of ORFs: i) putative – if both an in-frame start and an in-frame terminal codons were 
present; ii) N-terminal – if the start codon was present, but the terminal codon was missing; 
iii) C-terminal – if the start codon was missing, but the terminal codon was present; iv) partial 
– if neither start nor terminal codon were present, but the ORF spun the whole contig 
(FIGURE 2.18). 
 
FIGURE 2.18: ORF classes. The rounded edge denotes the beginning or end of the ORF irrespective 
of the contig start or end. Sharp end denotes the beginning or end of the contig itself. 
Non-coding RNAs have been identified using the latest release of the Infernal database and 
accompanying software [NAWROCKI ET AL. 2013] (http://infernal.janelia.org/). 
 
 
2.2.11 GENOMIC DATA 
The genome and the transcriptome provide two complementary pieces of information about 
the genetic constitution of an organism and the gene expression profiles in different cell 
types and tissues, respectively. The transcriptome data do not include any regulatory 
sequences, as those are not transcribed. Nevertheless, these sequences could have an 
important role in regeneration. 
As long error-corrected PacBio reads of axolotl genomic DNA became available [FEI, MYERS, 
PIPPEL unpublished] towards the end of my project, it gave me a possibility to improve the 
transcriptome assembly. I identified contigs that had clear homologs at the genomic level 
over their entire length and generated partial genomic sequences of their respective loci. 
The dataset comprised of 106,480,905 reads with the average length of 5,456bp. The total 
length was 581,014,569,769bp with the respective coverage of approximately 18x. 
To this end I first compared (blastn, minimal identity 95%) the contigs with the collection of 
PacBio reads to identify strong homologs. If a contig was covered by at least one PacBio 
read over at least 95% of its length it was labeled as verified. Subsequently, the reads that 
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mapped to the same contig were assembled using CeleraAssembler [MYERS ET AL. 2000] to 
generate the sequence of the respective genomic locus. 
It was shown before that the genome of the axolotl contains large introns [SMITH ET AL. 
2009]. Many transcripts could not be verified using genomic PacBio reads, as the reads that 
spun exons ended in introns and did not overlap. I applied a different approach to rebuild the 
genomic sequences of such loci. Inspired by the primer walking approach for sequencing 
large fragments of DNA [SVERDLOV ET AL. 2001] I performed an in silico primer walking 
starting from the 3’ end of a read that mapped to the 5’ end of the contig and looked for an 
overlap with the 5’ region of another PacBio read, thus, extending the genomic sequence. 
Given the large total number of the reads, the major problem was to find an overlap 
between two PacBio reads as it was not feasible to blast them all against all. Therefore, I 
approached the problem in a different way outlined in FIGURE 2.19.  
 
FIGURE 2.19: Assembly of the genomic PacBio reads. a. A set of short sequences is generated 
from the ends of the original long reads. b. The short sequences are mapped to the long reads, thus, 
providing the overlap information. c. The mapping is used to build overlap graphs that can be 
traversed to build longer assembled sequences. 
In a collection of PacBio reads PB-R1 – PB-R4, the reads PB-R1 and PB-R3 and the reads PB-
R2 and PB-R4 overlap. In order to identify the overlapping reads, short 100bp sequences 
were generated from both ends of all PacBio reads – R1L-R4L and R1R-R4R, respectively. 
Those short sequences were treated as Illumina reads and subsequently mapped to the pool 
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of PacBio reads using any common mapping software, such as Botwie2 [LANGMEAD ET AL. 
2012]. Each short sequence had to map to its original PacBio read. If it additionally mapped 
to another PacBio read, it indicated that the two reads overlap. This way an overlap graph 
could be built and subsequently used to assemble the reads. 
 
 
2.2.12 ASSESSMENT OF COMPLETENESS 
I used three independent ways to assess the completeness of the assembly: i) using the set 
of ESTs; ii) comparing the mapping ratio of the Illumina reads to the transcriptome and to the 
genomic reads; iii) using the protein families data. 
For the first method I downloaded 60,000 axolotl EST sequences from the NCBI and blasted 
them (blastn, e-value cutoff 1e-50) against the transcriptome assembly in order to find 
homologous sequences. Additionally, I used an independent set of 213 cDNA sequences 
that were not used for the assembly and also blasted them against the assembly. If the 
query sequence had at least one homologous contig, which covered the query to at least 
90%, it was considered as present in the assembly. The query sequences absent from the 
assembly have been analyzed further.  
Another independent way to assess the completeness of the transcriptome was to map all 
original reads back to the transcriptome. In case of good quality RNA-Seq data, over 90% of 
the reads should be mapped to the reference, which sets the baseline mapping rate value. 
For the third method I fetched the set of all genes of the seven RefSeq organisms and their 
respective gene families from the Ensembl database [CUNNINGHAM ET AL. 2015]. Further, I 
searched for their homologs in the axolotl assembly. Additionally, I calculated the number of 
common families, i.e. the ones that have at least one representative protein in each RefSeq 
organism, and estimated to which extent those families were present in the transcriptome.  
  
	44	
2.3 RESULTS 
2.3.1 ASSEMBLY 
After quality assessment and data filtering, approximately 900 million Illumina, 17,522 
Sanger, 1.2 million Roche/454 and 700 thousand PacBio reads were obtained from different 
libraries (see 2.2.1 Tissue Samples and Data). 
For simplicity I will subsequently collectively refer to unassembled Sanger, Roche/454 and 
PacBio reads as ESTs. 
As outlined in 2.2.8 Transcriptome Assembly, I decided to assemble the short Illumina 
reads and the long ESTs independently. Since the size of the Illumina dataset was 
enormous, technical properties of the computer system, such as the amount of RAM, 
became limiting factors. Ideally, Trinity requires approximately 1GB of RAM per 1 million 
reads. Therefore, I had to split the datasets into several parts and assemble them 
individually. There were two possibilities: i) an incremental assembly (FIGURE 2.20) and ii) a 
parallel assembly (FIGURE 2.21). Their advantages and disadvantages are briefly discussed 
below. 
 
FIGURE 2.20: Incremental assembly. Reads from the dataset 1 are assembled first. Then the same 
reads and the reads from the dataset 2 are mapped back onto the contigs and unmapped pairs (e.g. 
the pair of reads shaded in blue) are used to create a new dataset, which, in turn, is assembled. 
In the former the reads from one dataset are assembled first. Then the reads from the same 
dataset and another dataset that was not used for the assembly are mapped back to the 
assembled contigs. The paired reads that do not map as proper pairs are used to create a 
new dataset of unmapped reads that is used to create another assembly, which is merged 
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with the previous one. Afterwards, the entire procedure is repeated until all datasets have 
been used.  
Since many transcripts are ubiquitous in different cell and tissue types, the reads that 
contribute to the contigs that were already assembled are removed from the data pool, thus, 
reducing its size. However, if a transcript fails to be assembled in one round but is rather 
represented by two or more fragments, it is unlikely that those will be joined in a 
subsequent round. The reason is that transcript fragments arise when there are no reads 
that could bridge the gaps between the fragments. Such gaps are usually very short and are 
likely to arise at positions within transcripts that are covered by only a few reads. In this case 
a single missing read could already lead to a gap that cannot be closed. Since the gaps are 
short, even if the reads that cover the gap are present in the next dataset, the resulting mini-
contigs are too short and discarded. 
In contrast, in the parallel assembly all datasets are assembled independently and the 
resulting assemblies are merged afterwards. Ubiquitous transcripts that are present in all 
assemblies (green) will be present only once in the final assembly, while all different 
transcripts (blue) will be kept. If a transcript fails to be assembled in one of the assemblies 
(red) but not in the other, the more complete contig is included into the final assembly.  
 
FIGURE 2.21: Parallel assembly. Reads from the individual datasets are assembled independently 
and the partial assemblies are merged afterwards. 
However, I noticed that the size of the merged assembly increased with the number of 
individual dataset assemblies. For instance, the datasets of mature and 6 dpi spinal cord 
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yielded 175,261 and 191,560 contigs, respectively, whereas the merged assembly 
comprised 283,375 contigs. Moreover, the mean length of the contigs decreased from 
1,068 and 1,052, respectively, to 987 in the merged assembly. This indicated that many 
short contigs representing fragments of the same transcripts failed to be joined. Therefore, 
this approach was also discarded. 
Luckily, in the new release of Trinity (r20140717) a big improvement has been made in 
terms of memory demand. It became possible to simply pool together all reads that passed 
through the filters and assemble them.  
For the final assembly all Illumina reads were pooled together and assembled by Trinity. All 
ESTs were assembled separately using Mira (v.4.9.3) [CHEVREUX ET AL. 2004]. The 
subsequent merging of both assemblies allowed me to join a few Illumina-based fragments 
that belonged to the same transcript, but failed to be joined due to the lack of coverage at 
the junction (FIGURE 2.22).  
 
FIGURE 2.22: Fragmented contigs. Both contigs belong to the same transcript, but failed to be 
joined due to the lack of coverage at the junction site. They could, however, be joined when both 
aligned to a Sanger read. 
In the majority of cases the ESTs were completely contained within the Illumina contigs. 
This indicated that the coverage offered by the Illumina reads was sufficient to create a 
transcriptome assembly.  
Trinity is a transcriptome assembly tool and is, therefore, aware of splicing. It tries to 
generate multiple transcriptional isoforms of the same gene in order to capture the 
variations in the read data. If an exon E is skipped in one isoform but not the other, there will 
be reads originating in the exon previous to E and ending in the exon following E 
(FIGURE 2.23).  
 
FIGURE 2.23: Isoforms. If there are reads that skip one exon (orange bars), then multiple isoforms are 
generated in order to explain such variation. Green bar represents all exons concatenated together. 
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After the final merged assembly was finished, I clustered the isoforms into transcribed units 
based on similarity. Since no underlying genomic data were present, the transcribed units 
are not quite the same as genes, as they lack comprehensive intron data. 
The latest assembly (Am_25) consisted of 91,552 contigs grouped into 75,939 transcribed 
units. The shortest contig was only 201bp and the longest is 32,687bp long (mean length 
1,606bp).  
I also estimated the coverage of the transcriptome by mapping the Illumina reads to the 
transcripts as 
𝐶 = -./0012×)**×4
5
, 
where Nmapped is the number of mapped reads and L is the combined length of all contigs. All 
datasets combined yielded 1,110,806,170 reads, of which approximately 80% mapped to 
the transcriptome. The 91,552 contigs of the assembly added up to 147,120,994 bases. 
Therefore, the estimated coverage was approximately 1,200 fold, which by an order of 
magnitude greater than the 50x coverage used to reconstruct E.coli genome [Illumina 
technical note]. 
 
a. Consistent read orientation. All forward/reverse reads have the same orientation within the 
contig. 
 
b. Controversial read orientation. The forward reads have opposing orientation suggesting that the 
contig might be a chimera. 
 
FIGURE 2.24: Reads orientation. Since the reads (blue and red bars) are strand-specific all forward or 
reverse reads must have the same orientation when mapped back to the contig (green bar). However, 
if the reads have controversial orientations it is an indication for either overlapping transcripts or an 
assembly chimera. 
While merging the Illumina-based assembly with the one constructed from the ESTs I 
noticed that the orientation of the contigs in the Illumina assembly was random. However, 
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the proper 5’→3’ orientation of the contig could be restored (FIGURE 2.24a) using strand-
specificity of the Illumina reads (see 2.2.4 Illumina Libraries for details). Therefore, if the 
direction of the reverse reads was consistent, the orientation of the contig was forced to 
match that given by the orientation of the forward reads. I also identified a few contigs in 
which the orientation of individual forward (or reverse) reads was not consistent suggesting 
that those contigs might be chimeras or represented true cases of overlapping transcripts 
(FIGURE 2.24b). This issue could be resolved using the transcriptome data only. 
 
 
2.3.2 ANNOTATION 
The contigs were annotated using the most recent release of the RefSeq database (v.72, 
release date 2015-09-03). Out of 91,552 contigs 38,968 (43%) had homologs in the RefSeq 
database and could be annotated. 54% of the annotated contigs were strong homologs and 
12% were putative homologs, while similar and weak homologs made up 17% each 
(FIGURE 2.25a). 
Overall 47,896 (52%) of all contigs had an open reading frame regardless of its class (see 
Materials and Methods). In case of 38,854 contigs the ORF was based on the annotation. 
The majority of those (53%) were likely to be full-length ORFs, since they had both the start 
codon and a proper terminal codon (FIGURE 2.25b).  
 
FIGURE 2.25: Annotation results. a. 41% of all contigs have a RefSeq homolog. b. 43% of all contigs 
have an ORF. c. 41% of all contigs have at least one known protein domain. 
	 49	
Independently of the annotation, 37,333 (41%) contigs had at least one known protein 
domain from the InterProScan database (FIGURE 2.25c). 
Very similar numbers of contigs with a N-terminal or a C-terminal ORF suggested that some 
contigs might still be fragmented. A fairly large proportion of the ORFs bearing a premature 
terminal codon (PTC) could arise due to sequencing mistakes that either yielded a terminal 
codon where there was none or caused a frame shift resulting in a terminal codon. It could 
also indicate the presence of the pseudogenes that are, nevertheless, transcribed, but most 
likely non-functional [VANIN 1985]. 
If a contig covered at least 90% of the respective RefSeq homolog sequence, it was termed 
a full-length homolog (FIGURE 2.26). 
 
FIGURE 2.26: Full-length ORFs. The numbers of full-length ORFs are similar to those of putative 
ORFs for all four classes of homologs. n total number of contigs in a category, n number of full-
length homologs, n number of full-length homologs that have a putative ORF. 
The number of full-length homologs was significantly lower than the total number of 
homologs in each group, indicating that quite some contigs were fragmented. To solve this 
problem additional sequencing was required. It was also evident that some full-length 
homologs did not have ORFs, which had both the start and the terminal codons. This could 
happen due to sequencing or assembly mistakes that render a terminal codon within the 
aligned portion of the transcript, changing its class from putative to PTC. Alternatively, 
mistakes could also remove either the start or the terminal codon from the contig, which 
also altered class of the respective ORF. Aligning the transcripts to the corresponding 
genomic loci could solve both problems. However, in many cases the genomic sequence 
could not be reconstructed due to long introns (see 2.4 Discussion). 
To identify potential contamination (see 2.2.9 Potential Contamination) I blasted the 
contigs against the UniVec and nr databases. Only 153 contigs turned out to be 
contaminants. 
It was tempting to ask the question which proportion of each respective RefSeq dataset had 
homologous contigs in the axolotl transcriptome. There were two ways to address this 
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question: i) on protein level, counting how many proteins have homologous axolotl contigs 
and ii) on gene level, counting only how many genes have homologs.  
For the first approach, a gene was counted as a hit if at least one of its proteins had a 
homolog in axolotl. The second method is slightly more accurate as RefSeq datasets often 
contain many different protein sequences (sometimes from different species, e.g. Mus 
musculus, Mus musculus domesticus and Mus musculus castaneus for the mouse) for the 
same gene, which all represent very similar isoforms. To this end I clustered different 
proteins in each RefSeq dataset based on similarity (similarity cutoff 95%) prior to 
identification of homologs. 
60% or more of the genes in each RefSeq dataset had homologs in the axolotl, whereas on 
protein level this number was slightly lower (FIGURE 2.27). 
FIGURE 2.27: RefSeq coverage.  On gene level more than 60% of the genes of all RefSeq organisms 
have a reciprocally best homolog in the axolotl transcriptome. 
 
 
2.3.3 ASSESSMENT OF COMPLETENESS 
As outlined in 2.2.12 Assessment of competeness, I used three different and independent 
methods to assess the completeness of the transcriptome assembly. 
First I compared a set of 213 cDNA sequences with the transcriptome. Only four of them 
did not have homologs in the assembly and were subsequently analyzed manually. One 
turned out to be a highly tissue-specific transcript from the jaw – a tissue that was 
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sequenced neither by Illumina nor by Sanger, Roche/454 and PacBio. Therefore, it was not 
surprising that it was absent. 
Another thee cDNAs represented very lowly expressed genes from the tissues that were 
sequenced. However, when I mapped the Illumina reads to them, I saw that only a few 
reads mapped, meaning that there was not enough coverage to reconstruct those 
transcripts. 
Similarly, 96% of the 60,000 ESTs downloaded from the NCBI had homologs in the 
assembly. The remaining 4% were too short to generate e-values lower than the threshold. 
Some of the ESTs longer than 200bp indeed did not have homologs. However, since the 
Illumina reads mapped very sparsely to those contigs, I could not exclude the possibility of a 
contamination by the transcripts from another species. Therefore, I did not include those 
additional sequences in the assembly. 
Second, I mapped the Illumina datasets to the transcriptome and to the genomic PacBio 
reads (see 2.2.11 Genomic Data). 82% and 91% mapped to the transcriptome and to the 
genome, respectively, whereas 4% of the reads only mapped to the transcriptome. 
While the reads that map to the genome but not the transcriptome most likely originated 
from the transcripts, which failed to be assembled, the presence of the reads that map to 
the transcriptome but not the genome was remarkable. I identified some of those reads and 
analyzed their mapping. It turned out that some of those reads crossed the exon-exon 
junctions of their respective transcripts. If PacBio reads were not long enough to span the 
entire intron, the mapping was not possible (FIGURE 2.28). Additionally, it must be taken into 
account that the genome was represented by a set of reads rather than of assembled 
sequences. 
 
FIGURE 2.28: Mapping to the transcript vs genomic reads.  If the Illumina read (blue) originates 
from the exon-exon junction, it must be split when mapping to the genome. Since PacBio Read 1 
does not span the intron completely, the Illumina read will fail to map to it. It will, however, map to 
PacBio read 2. 
On the other hand, approximately 10% of all reads mapped to the genomic reads but not the 
transcriptome. Such mapped reads were not scattered over the entire PacBio dataset, but 
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were rather concentrated over relatively small (several hundred thousand) number of PacBio 
reads, suggesting that some of the transcripts might have remained undiscovered and 
unassembled. They could also originate from spliced introns (see below) or short transcripts 
that were not assembled by Trinity. 
Finally, I assessed the completeness of the assembly using a method that did not require 
sequencing data. I calculated the number of protein families annotated for each RefSeq 
organism and also the number of unique protein families that did not have homologs in other 
RefSeq organisms (FIGURE 2.29). Human proteins belong to approximately 28 thousand 
different protein families, while approximately 15,500 of them are unique. Of the remaining 
12,500 families, 10,000 had homologs in axolotl. X.tropicalis is closest to axolotl based on 
that analysis, as 90% of its protein families had homologs in axolotl. 
 
FIGURE 2.29: Coverage of Ensembl protein families.  The number of protein families in each 
organism and the number of those that have homologs in the axolotl. 
While families unique to a particular organism represent a significant proportion of the total 
number of families, I decided to use protein families that are present in all RefSeq organisms 
to estimate the coverage. There were 7,695 common families and 7,568 of them have 
homologs in the axolotl transcriptome. 
Based on the above analyses I concluded that while the fraction of the axolotl transcriptome, 
which comprises proteins common to multiple organisms, was mainly complete, additional 
sequencing and assembly was necessary to capture some tissue- or stage-specific 
transcripts and transcripts expressed at very low levels.  
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2.3.4 CONTIG VERIFICATION 
I used the genomic PacBio reads to verify the contigs. A contig was labeled as verified if it 
was covered by at least one genomic PacBio read over at least 95% of its length. 43,036 
(47%) of 91,552 contigs were verified this way. 
While analyzing the transcripts, I identified approximately 700 transcripts that seemed to 
represent introns, which were not completely spliced out by the time the RNA was captured 
for sequencing and, thus, ended up in the sample and were sequenced (FIGURE 2.30).  
 
FIGURE 2.30: Unspliced introns.  The gray outline represents a long PacBio read, while the green 
bars represent the aligned contigs (one per line) and their mapping location within the PacBio read. 
The contig AC_02200044868.1 (bottom line) has, therefore, 4 exons. Other three contigs are likely to 
represent the introns. The sequences GT and AG indicative for intron 5’ and 3’ ends, respectively are 
highlighted and the intron-exon boundaries indicated by read arrowheads. Note that the transcript and 
the putative intron overlap.  
The presence of unprocessed introns has already been addressed in the literature [AMEUR ET 
AL. 2011]. In order to verify the example depicted in FIGURE 2.30, I designed several pairs of 
PCR primers based on the contig sequence and amplified genomic DNA using those 
primers. I sequenced the resulting fragments from both ends by Sanger sequencing, aligned 
the individual sequences, their respective genomic PacBio read and the four contigs in order 
to validate the finding. Only the contig 02200044868.1 seemed to represent a fully 
processed transcript as it has a predicted ORF and is supported by several ESTs over 90% 
of its length (FIGURE 2.31). 
 
FIGURE 2.31: Library sequences supporting the contig.  The green and blue bars represent the 
regions of the contig that are covered by a library sequence on either forward or reserve strand, 
respectively. 
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The remaining three contigs have much lower number of Illumina reads mapping to them 
indicating their low abundance in the sample. Another line of evidence was that none of 
them was supported by the ESTs. Finally, I carefully examined the sequence of those 
contigs and found the GT sequence within the first 20bp at the 5’ end and the AG sequence 
within a similar range at the 3’ end of the contig, which is characteristic for group II self-
splicing introns [BLACK 2003; KNAPP ET AL. 1978; KONARSKA ET AL. 1985; PATEL ET AL. 2003; 
ROY ET AL. 2006] (FIGURE 2.30, bottom panel). 
From this evidence, I concluded that the identified contigs indeed represented a true 
transcript and three introns. Interestingly, the introns overlapped by 10-20 bases with the 
sequence of the fully processed transcript. The overlaps were, however, too short and, thus, 
discarded by the assembly software. 
The presence of short characteristic intronic sequences at the ends of the contigs also held 
true for all identified putative introns. However, since such contigs could still carry out an 
unknown regulatory function, they were not removed from the assembly.  
 
 
2.3.5 SECONDARY APPLICATIONS 
The transcriptome assembly is an important tool for molecular biological and comparative 
research. There are a number of secondary applications the transcriptome data can be used 
for. One example is to design a custom microarray for differential expression studies. 
Despite of advances in the field of next generation sequencing, the microarrays have a 
proven track record spanning almost two decades in the lab. As a result there are a lot of 
analysis tools and methods available for microarray data. Even though the microarrays suffer 
from the design bias meaning that they can only be used to analyze the probes they were 
designed for, they are often considered to be less complicated and require less labor-
intensive sample preparation. For this reason, together with Dr. Dunja Knapp and Dr. Prayag 
Murawala I designed a new custom microarray that covered a much broader spectrum of 
transcripts than the microarray used in previous studies [KNAPP ET AL. 2013]. 
We used the proprietary web application eArray (https://earray.chem.agilent.com/earray) 
provided by Agilent to design the probes. Each Agilent microarray slide contained two 
identical microarrays. Each microarray contained 420,288 60nt-long probes, 3,783 of which 
were Agilent controls. We designed different number of probes for each contigs depending 
on its properties and available annotation (TABLE 2.5). 
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Type of contigs Number of probes Remarks 
Annotated 3 sense, 1 antisense  
Non-annotated 3 sense, 3 antisense  
EST-only 3 sense, 1 antisense EST-only are contigs that originate 
from the EST assembly and were 
not present in the Illumina 
assembly. Since the orientation is 
explicitly defined by the way the 
libraries were constructed, a 
single antisense probe is 
sufficient 
Conflicting 3 sense, 3 antisense Since the contig orientation 
cannot be deduced, it is safer to 
have more probes 
TABLE 2.5: Microarray composition. 
The probes of the old microarray were also included in the new microarray if at least 55 of 
the 60 bases in the probe were homologous to those of its respective target. Therefore, the 
new microarray was partially backwards compatible to the old microarray. However, if the 
old probe had an identical counterpart in the new microarray, only one copy was kept in 
order to remove redundancy. 
Another important secondary application of the transcriptome was the estimation of the 
codon usage, which is a statistical property of DNA sequences that encode proteins 
[PLOTKIN ET AL. 2006; HERSHBERG ET AL. 2008]. Although the genetic code is degenerated 
meaning that several codons can encode the same amino acid [ALBERTS ET AL. 2002; 
WATSON ET AL. 2013], it has been observed that the genes do not use all available codons 
randomly, but show a certain preference for particular codons [PLOTKIN ET AL. 2010; FOX ET 
AL. 2010]. Unlike the genetic code, which is mostly universal, the codon usage is unique for 
each species [PLOTKIN ET AL. 2004]. The codon usage is an important factor for gene 
expression as the codon preference correlates with the abundance of the respective tRNA. 
In order to increase the expression efficiency the most frequent codons should be used 
[NOVOA ET AL. 2012]. 
I used the subset of contigs, which had a putative ORF to estimate the codon usage 
frequencies for the axolotl transcriptome (FIGURE 2.32). 
The frequencies of the codons estimated from the assembled and annotated sequences 
were very similar to those determined in other studies [SAMUELS ET AL. 2005]. As expected, 
the frequencies were quite different between the axolotl and other non-salamander 
organisms. The data for comparison were taken from the Codon usage database [NAKAMURA 
ET AL. 2000].  
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FIGURE 2.32: Codon usage. The expected usage frequency of a codon is 1/N, where N is the number 
of synonymous codons. However, some codons are used less (orange) or more (blue) frequently.  
 
 
2.3.6 WEB PORTAL 
The research communities working with other model organisms like Xenopus or Drosophila 
have established web portals that provide different comprehensive data related to their 
organism of interest. Therefore, not only was it necessary to assemble the transcriptome, 
but it was also crucial to make this information accessible for the entire axolotl research 
community. Designing and setting up a web portal for the axolotl transcriptome – 
https://www.axolotl-omics.org – was a large part of the project.  
The web portal provides the basic information for all contigs such as the nucleotide 
sequence, predicted ORF, annotation, and homologs as well as more advanced details such 
as microarray probes with their respective mapping, time course expression profiles based 
on microarray and next generation sequencing data, and, finally, phylogeny data based on 
homologous alignments to relatively closely related species like the newt and Xenopus. 
In order to make the web portal a comprehensive resource of information I also integrated 
the BLAST search engine into it and put together all different bits of information such as 
ESTs from NCBI and our own libraries, annotated pathways of contigs and in situ 
hybridization images (if available) in one place. 
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To date, many analyses are performed computationally rather than manually. To this end I 
developed an Application Programming Interface (API) to the website to allow for automated 
data fetching.  
While some of key features of the web portal are described below, the full documentation 
including the database entity relationship (ER) model and the comprehensive API 
documentation can be found online (https://www.axolotl-omics.org/documentation). 
 
 
2.3.6.1 REFSEQ HOMOLOGS 
Since the transcriptome was annotated automatically by blasting the RefSeq proteins 
against the assembly, it was crucial to provide the alignment details to the user, such that he 
or she can ultimately decide whether the annotation is correct. 
Therefore, a list of homologous proteins from all seven RefSeq organisms is provided for all 
annotated contigs (FIGURE 2.33). 
 
FIGURE 2.33: Homologs view.  A list of homologous proteins from all seven RefSeq organisms is 
provided for each annotated contig along with the respective alignments. 
 
The grey outline represents the contig itself and the numbers indicate each 10% of its 
length. The bar in the first line indicates the annotated ORF and its type, while other lines 
indicate the homologous alignment between the respective protein and the contigs along 
with the location of the homologous alignment within the contig. As can be seen in the 
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figure, the homologous alignment either co-localizes with the ORF in case of a full-length 
homolog, or is contained within the ORF otherwise. 
 
 
2.3.6.2 LIBRARY HOMOLOGS 
Another important piece of information is the homology between the contigs and the library 
sequences. This is particularly important for probe design for in situ hybridization or in other 
cases, when having a physical clone containing the sequence of interest is required. 
The library homologs view is organized in a similar fashion to the RefSeq homologs view 
with the only difference that the bars indicating the position of the homologous alignment 
may be green or blue to indicate that the library sequence orientation is the same as that of 
the contig or the opposite, respectively (FIGURE 2.34). All ESTs and cDNAs from our lab were 
sequenced in 5’ to 3’ orientation; however, the orientation of the sequences downloaded 
from the NCBI may vary. 
 
 
FIGURE 2.34: Library sequences mapping. The first line displays the outline of the ORF if applicable. 
The exact location of the homologous alignment within the contig is indicated by the green (same 
strand) or the blue (reverse complement) bars.  
 
 
2.3.6.3 COVERAGE 
Although reads/fragments per kilobase per million mapped reads (RPKM or FPKM, 
respectively) was introduced as a measure for expression level [MORTAZAVI ET AL. 2008], it is 
still debated whether or not it should be used for differential expression analysis between 
the different samples. Raw reads counting [WU ET AL. 2013; ROBINSON ET AL. 2010; SIGOVA ET 
AL. 2013; ANDERS ET AL. 2010; ANDERS ET AL. 2014B], in contrast, is often used to identify 
genes that are differentially expressed. For both measures the reads must be mapped to the 
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reference. In case of the transcriptome assembly I mapped the original Illumina reads to the 
contigs. Unlike for the assembly itself, the reads were not filtered for mapping.  
The coverage view combines both of the above measures – it displays the mapping of the 
reads along the contig and the resulting FPKM value (FIGURE 2.35a). 
Clicking on the image opens a new view based on JBrowser [SKINNER ET AL. 2009] that 
allows for viewing the mapping details of individual reads (FIGURE 2.35b). 
JBrowser additionally displays the single nucleotide mismatches between the contig 
sequence and the reads, which allows for viewing the level of polymorphism for each 
individual site. By design, it also allows for uploading custom mapping data as binary 
sequence alignment/map (BAM) files [LI ET AL. 2009], which facilitates comparisons to 
additional datasets not present on the web portal. 
 
a.  The view displays both, the number of reads at each individual position along the contig and the 
respective FPKM value. 
 
b.  The view displays the mapping details of individual reads. 
FIGURE 2.35: Coverage view. The view provides the coverage information and a more detailed 
mapping information of individual reads. 
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2.3.6.4 TIME COURSE DATA 
There are quite some published microarray and next generation sequencing time course 
data available. However, it is important to see those data in context. Therefore, the data 
were mapped onto the transcriptome, such that for each contig the data from a number of 
experiments can be displayed. 
Although strictly speaking the microarray time course experiments cannot be directly 
compared to the next generation sequencing experiments putting both next to each other 
can provide additional line of evidence for the expression profile (FIGURE 2.36).  
 
 
a. A time course profile of a contig based on microarray data. 
 
 
a. A time course profile of the same contig based on next generation sequencing data. 
FIGURE 2.36: Time course view. Although microarray and next generation sequencing data are not 
directly comparable, they can still complement one another. 
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2.3.6.5 WEB PORTAL API 
It is possible for third-party tools and scripts to retrieve information from the axolotl-omics 
web portal using the Application Programming Interface (API). 
The API methods are called using the following syntax: 
https://www.axolotl-omics.org/api?[PARAMETERS STRING] 
[PARAMETERS STRING] must be a sequence of parameter-value pairs separated by the 
ampersand (‘&’) character. 
Some of the parameter names are reserved (TABLE 2.6), while others completely depend on 
the API module.  
 
Parameter Description 
method Specifies the method to call. The syntax is <MODULE>.<METHOD> 
format (optional) specifies the format of the returned data. Currently, only 
‘XML’ and ‘JSON’ are supported 
requestID (optional) specifies a user-defined value that is returned to the caller 
and can be used to discriminate results of different API calls 
callbackParams (optional) specifies a user-defined string that is returned to the caller 
and may contain additional parameters required for subsequent data 
processing 
TABLE 2.6: Common API parameters. 
All methods return an integer value to indicate the result. The exact value depends on the 
module, however, there are a few common values described in TABLE 2.7. While the return 
values are integers, there are human-readable names for them used throughout the 
documentation for convenience.  
 
Value Human-readable name Description 
0 ERR_OK Operation succeeded 
6 ERR_DB_ERROR The connection to the database could 
not be established 
4 ERR_MALFORMED_QUERY The query is malformed, e.g. empty 
1 ERR_METHOD_NOT_FOUND The specified method could not be 
found 
TABLE 2.7: Common return values. 
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Since the API is constantly updated, the most up-to-date documentation can be found 
online: https://www.axolotl-omics.org/documentation.  
 
 
2.3.6.6 USER INTERFACE 
In order to make the web portal user friendly I introduced several features like bookmarks, 
which allow the user to mark a sequence – contig, library sequence, microarray probe – as 
bookmark and easily find it later. The web portal also keeps track of recently viewed pages 
and submitted Blast searches. All those data can be accessed in the user profile.  
The search helps to find contigs by the name or by the name of the homologous library 
sequence, RefSeq sequence or microarray probe. 
To date, BLAST became one of the most frequently used and indispensable computational 
tools in biology. Considering the growing amount of sequencing data, it is often the fastest 
and the most reliable way to find the sequence of interest or its homologs in a large dataset. 
On the axolotl-omics website it is possible to blast against many different databases, 
including but not limited to several releases of the transcriptome assembly, different EST 
libraries and collections of reads (e.g. genomic PacBio reads). 
 
 
2.3.6.7 EXTENSIONS 
The architecture of the web portal has been designed to be easily extendable. Therefore, 
new modules – both, the views and the API modules – can be added without updating the 
web site engine. Each API module represents a simple Perl module that must implement a 
certain interface. The Perl module file can then be copied into the API directory on the web 
server and immediately becomes available for third-party use. An example of a simple API 
module can be downloaded from https://www.axolotl-omics.org/documentation/examples. 
The user interface itself can also be extended easily. Each view is a directory that must 
contain three files: view.xml, XXX.js and XXX.css, where XXX is an arbitrary name. 
The file view.xml is loaded automatically by the web site engine. It must describe the view 
and specify the types of data this view is suitable for. The structure of the file is shown in 
FIGURE 2.37. 
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FIGURE 2.37: Example of a view.xml file. The view.xml file describes the view and specifies the 
types of the sequences it supports. 
The files declared as dependencies are loaded automatically when the view is embedded 
into the webpage. The web site engine decides whether to embed the view based on the 
sequence type specified by seqtypes parameters. An example of a simple view can also be 
downloaded from https://www.axolotl-omics.org/documentation/examples. 
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2.4 DISCUSSION 
The axolotl, Ambystoma mexicanum, is an important model organism for regeneration and 
developmental studies. Therefore, its genomic information is indispensable for various 
functional analyses at the molecular level. However, although the modern sequencing 
platforms can generate enough data for a reasonable prize, it still remains computationally 
very challenging to reconstruct the whole genome mainly due to its large size. The majority 
of research projects, nevertheless, do not require comprehensive genome information as 
they are mostly focused on changes in gene expression. The transcripts are usually shorter 
than the respective genes and represent individual molecules. They are much easier to 
assemble and yet provide valuable information for molecular biological and comparative 
studies. 
A de novo transcriptome assembly in the absence of the reference genome poses several 
challenges that cannot be easily (if at all) resolved. The first and most important issue is the 
chimeras that arise when the assembly algorithm erroneously fuses independent transcripts 
into a single contig due to a homologous region. This can either be a low-complexity repeat 
or a highly conserved sequence as often found in paralogs sharing extensive homology over 
a substantial region (FIGURE 2.38).  
 
FIGURE 2.38: Example of a chimera. The contig is likely to represent a chimera that arose due to 
fusion of two transcripts that share a highly conserved domain (yellow). 
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If the yellow conserved domain is blasted (tblastn) against the transcriptome assembly, it 
hits both, a contig annotated as Tbx3 and a contig annotated as Tbx2 with the similarity of 
95% and 100%, respectively. While the respective contigs exhibit similarity of 91% within 
the conserved region, they fail to be aligned outside of that region. 
Although such candidate fusion chimeras could be identified by identifying two distinct 
transcripts that could have been erroneously joined together to form a third chimeric contig 
[EDGAR ET AL. 2011], in the absence of the assembled genome it still remains challenging to 
prove that the putative chimeric transcript does not exist as a single transcribed genomic 
locus [IYER ET AL. 2011].  
There were several lines of evidence that a few contigs could represent chimeras that arose 
due to misassemblies and misalignments caused by the false overlaps in either highly 
conserved or repetitive regions of paralogous transcripts. For instance, such contigs failed to 
be amplified by PCR. However, they could not be detected reliably as they alternatively 
could be true cases of transcript fusion – an event of trans-splicing of two individual 
transcripts [MITELMAN ET AL. 2007; RICKMAN ET AL. 2009; LI ET AL. 2008; LUO ET AL. 2015]. 
This kind of chimeras is much more common in contigs generated from Illumina reads, than 
from ESTs, since the length of the conserved region is much shorter than the average length 
of a single EST. Therefore, the majority of the ESTs would span such regions and not 
generate false overlaps.  
Closely related to the chimera issue is the presence of contigs with inconsistent orientation 
of the mapped reads described in 2.3.1 Assembly. While such contigs may represent 
chimeras, the absence of a clear and long overlap between the reads with opposing 
directionalities suggests that another possible explanation for this phenomenon could be 
divergent transcription – a phenomenon recently described in literature [WU ET AL. 2013; 
SIGOVA ET AL. 2013].  
The introns of some highly expressed genes are also found in the assembly, but are 
significantly lower expressed than the fully processed transcripts. The most striking feature 
of such contigs is that they have short overlaps with the mature transcript that cross the 
exon-intron boundaries flanking the intron. Recent findings [MERKHOFER ET AL. 2014; PERALES 
ET AL. 2009] in the field of transcription and splicing shed light on the process of co-
transcriptional splicing [OESTERREICH ET AL. 2011]. Since the introns are spliced co-
transcriptionally, there are some nascent transcripts in various stages of completion in the 
sample that contribute the reads spanning the exon-intron junction to the sequencing 
sample (FIGURE 2.39).  
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FIGURE 2.39: Intronic contigs. The majority of the reads (red) span the exon-exon junction allowing 
for correct reconstruction of the mature transcript. However, a few reads also span the intronic 
sequence (yellow), which, therefore, also is assembled. 
Since the mature mRNA molecules are much more abundant, there are more reads that 
support the fully spliced version of the transcript. This allows the software to correctly 
generate a separate contig for the intron, but also raises the question whether some of the 
intronic sequences were erroneously included into contigs. This question can only be 
answered, when the genomic assembly is available.  
Among other things the contigs of the transcriptome assembly can be used as anchors to 
guide the process of genome assembly. However, it is only applicable to the reads that 
cover the respective gene loci. As proof of principle, I used the alignment of the genomic 
PacBio reads and one of the contigs as test dataset. Subsequently, I also used the digital 
primer walking approach described in 2.2.11 Genomic Data to check if I could identify the 
same set of overlapping genomic reads independently. While both methods produced 
overlapping lists of genomic PacBio reads, the list produced by the digital primer walking 
was longer as it additionally contained the reads from intronic and intergenic regions. I 
assembled some reads that had an average length of 10Kb and generated a 50Kb-long 
genomic sequence containing the test contig. The combination of both methods allows 
reconstructing genomic loci of genes that have long introns that are not spun by individual 
PacBio reads.  
Another particularly interesting and important question that can now be addressed using the 
transcriptome assembly is whether the axolotl has the Pax3 gene. Two paralogous 
members of the paired box (Pax) family of transcriptional regulators Pax3 and Pax7 have 
essential roles in the embryogenesis and during adulthood [CHALEPAKIS ET AL. 1994; GRUSS ET 
AL. 1992; JOSTES ET AL. 1990]. For instance, in axolotl satellite cells expressing PAX7 have 
pivotal role in axolotl muscle regeneration [SANDOVAL-GUZMÁN ET AL. 2013]. During vertebrate 
evolution both, Pax3 and Pax7 duplicated from an ancestral gene [HOLLAND ET AL. 1999]. 
Despite a significant functional overlap, each paralog developed its novel functions in various 
cell types [RELAIX ET AL. 2004]. However, the axolotl Pax3 gene could never be amplified in 
the lab, suggesting that it could be missing. 
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Using both, the transcriptome assembly and the collection of genomic PacBio reads it was 
possible to approach this long-standing issue. In collaboration with Dr. Jifeng Fei from our 
lab I first tried to identify the axolotl homolog of the Pax3 gene using a number of other 
organisms including human, mouse and zebrafish. The only hit with high similarity was 
annotated as Pax7 and the protein encoded by the annotated ORF was indeed more similar 
to the PAX7 proteins from each respective organism. Nevertheless, one possible 
explanation could be that the axolotl Pax3 gene is very lowly or not at all expressed in the 
tissues that have been sequenced. The collection of genomic PacBio reads provided the 
possibility to check if there is a homologous sequence on the DNA level. However, the most 
significant hit was again the locus containing the axolotl Pax7 gene. 
We finally applied a comparative genomics approach and exploited the fact that the genomic 
neighborhood of both, Pax7 and Pax3 genes is well conserved in a number of different 
organisms (FIGURE 2.40).  
 
FIGURE 2.40: Genomic neighborhood of Pax3 and Pax7. The neighboring genes outlined by green 
boxes are conserved in multiple vertebrates. While the neighboring genes Mogat1, Sgpp2, and Epha4 
are present in the axolotl, the Pax3 gene itself is not. 
Intriguingly, the neighboring genes of both paralogs are present in the axolotl transcriptome. 
With help of Dr. Michael Hiller from the Max Planck Institute for Cell biology we identified 3 
conserved non-genic elements (CNEs) [HILLER ET AL. 2013] in the introns of the frog Pax3 
gene and one additional CNE in the intron of the frog Pax7 gene, which have conserved 
homologs in both, the human and the chicken. As anticipated, while no hits were found for 
any of the Pax3 CNEs, a hit for the Pax7 CNE was identified in axolotl. This adds one more 
line of evidence to the assumption that the axolotl might have lost its copy of the Pax3 gene. 
In conclusion, not only can de novo transcriptome assembly provide a comprehensive 
transcript and annotation information, but it can also be used in a number of applications that 
are not limited to gene expression profiling. One of such applications is the interspecific 
comparison that aims to identify transcripts – not necessarily protein-coding – that are 
specific for a clade or lineage and participate in a certain process. 
In my work I used the transcriptome assembly in order to identify putative salamander-
specific transcripts that are likely to be implicated in the process of regeneration. 
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CHAPTER 
3 
 
FUNCTIONAL ANALYSIS OF A SALAMANDER-
SPECIFIC TRANSCRIPT 
 
3.1 INTRODUCTION  
Although most animals trigger a wound healing response after injury, only in a few of them 
the response leads to the activation of a successful regeneration program. Therefore, as 
already outlined in the introductory chapter, it is tempting to ask the question whether 
species with high regenerative capabilities have unique regeneration-specific genes that are 
missing in the animals with poor regenerative capabilities or if they possess the same 
repertoire of genes that is common for most vertebrates, but are able to activate different 
modes of gene regulation that are disabled in non-regenerating species. Another question 
follows from the pleiotropy view is to what extend the regeneration is a recapitulation of the 
development. 
In a recent study from our lab [KNAPP ET AL. 2013] those questions were addressed by 
analyzing the transcriptional profiles of the regenerating salamander limbs, healing lateral 
wounds and developing limb buds at different time points. Three distinct phases of 
regeneration were identified on the molecular level: i) the initial wound-healing phase, in 
which the genetic programs in both, regenerating and wounded limbs are highly similar; ii) 
the blastema formation phase, in which the above programs start to diverge; and iii) the re-
activation of developmental programs – a phase, in which the transcriptional profile of the 
regenerating limbs resembles that of developing limbs rather than of corresponding 
wounded limbs.  
In my work I primarily aimed to identify salamander-specific genes that are implicated in 
regeneration. I, therefore, first used the assembled axolotl transcriptome to carry out 
comparisons with the newt transcriptome, in order to identify axolotl transcripts that do not 
have homologs in non-regenerating vertebrates but are likely to be protein-coding. 
Afterwards, I used the transcriptional profiles data from the above study to identify the 
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genes that are significantly differentially expressed in the regenerating and the 
corresponding wounded limbs in the third phase of regeneration.  
In order to investigate the putative function of one such candidate gene in the regeneration, 
I employed the CRISPR/Cas system [SANDER ET AL. 2014; JINEK ET AL. 2012] that recently 
became available for axolotl [FEI ET AL. 2014] to create transgenic animals and examined their 
phenotype.  
 
 
3.1.1 CRISPR/CAS SYSTEM 
CRISPRs – clustered regularly interspaced short palindromic repeats – were first discovered 
in E.coli. They are segments of the bacterial DNA that contain short palindromic repeats 
followed by a short spacer DNA (FIGURE 3.1). Bioinformatics analyses revealed that the 
spacer sequences have high similarity to the viral or phage DNA. Additionally, a set of genes 
collectively termed cas (CRISPR associated) was found to be associated with the CRISPRs 
and encodes nuclease or helicase proteins that can cut DNA.  
Putting all pieces of the puzzle together it became clear that CRISPR/Cas system constituted 
a simple, but yet efficient RNA-mediated mechanism for protection against viruses and 
phages, in which the spacers result from previous exposures to a bacterial virus or phage.  
Whenever a virus or phage attacks a bacterium for the first time, a piece of the invading 
DNA is integrated into the CRISPR locus. Next, CRISPR-RNAs are transcribed from this 
locus, cut into small fragments called crRNAs, which are then incorporated into effector 
complexes. There they guide the complex to the invading exogenous DNA, which is 
degraded by the nucleases and helicases. Therefore, the system closely resembles the 
RNAi system in eukaryotic organisms.  
 
FIGURE 3.1: CRISPR locus structure. Cas genes are followed by a cassette of the palindromic 
repeats and spacers numbered 1-5 for clarity. CRISPR array is first transcribed into a pre-crRNA, 
which is later on cut in mature crRNAs by RNase III. 
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There are three types of pathways that activate the CRISPR/Cas mechanism. Trans-
activating crRNA (tracrRNA) plays an important role in one of them (called type II) in the 
maturation of crRNAs. It is complementary to the pre-crRNA and, thus, forms an RNA 
duplex with it. The duplex is cleaved by the RNase III and forms a crRNA/tracrRNA hybrid 
that guides CAS9, which is an endonuclease, to the targeted locus in the invading DNA 
(FIGURE 3.2). It was also shown that the fragments of the exogenous DNA that are 
incorporated into the CRISPR locus are not selected randomly, but instead were found 
adjacent to short (3-5bp) DNA sequences referred to as the protospacer adjasent motifs 
(PAM). The canonical PAM is associated with the CAS9 nuclease of Streptococcus 
pyogenes and has a consensus sequence NGG [ANDERS ET AL. 2014A].   
 
FIGURE 3.2: CRISPR/Cas-mediated cleavage. A 20-bp long gRNA guides the CAS9-containing 
complex to the target locus, where CAS9 recognizes the PAM sequence and cleaves the DNA before 
it, producing blunt ends [image from https://www.neb.com/products/m0386-cas9-nuclease-s-
pyogenes]. 
 
Jinek fused the tracrRNA and the designed spacer-containing RNA into a single synthetic 
chimeric guide RNA (cgRNA), which, mixed with CAS9 protein, could be used to cut DNA 
[JINEK ET AL. 2012]. The targeted DNA sequence is a 20-bp sequence complementary to the 
crRNA in the guide RNA, followed by the PAM sequence, which is recognized by the CAS9 
protein itself and is, therefore, essential for cleavage. Due to its simplicity, the CRISPR/Cas 
system quickly became one of the favorite tools in the field of genomic engineering and 
editing as it can be used to cut the DNA at any desired locus (provided that the PAM is 
present at that locus) by simply delivering the Cas9 mRNA or protein and the appropriate 
guide RNA into the cell. 
After the injection of Cas9 mRNA or protein along with the guide RNA into the cell, the 
CAS9 protein is guided to the targeted location and generates a double-strand break.  
While both normal metabolic activities and environmental factors such as UV light can cause 
DNA damage [DARNELL ET AL. 1986], they usually introduce lesions in a single strand, to 
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which end eukaryotic cells have evolved a variety of repair mechanisms. However, almost all 
repair mechanisms rely on the presence of an undamaged strand opposite to the lesion, 
which can be used as template for repair. In case of a DSB both strands are damaged, 
meaning that no template is available for repair. Cells, therefore, evolved three alternative 
repair mechanisms to deal with DSBs and restore the integrity of the DNA (FIGURE 3.3). 
Those mechanisms can be divided in two categories: i) homology-dependent and ii) 
homology-independent. 
The former is also called homology-directed repair (HDR) [PARDO ET AL. 2009; BOLDERSON ET 
AL. 2009] and relies on the presence of a homologous DNA piece both endogenous or 
exogenous, e.g. plasmid, that can be used as template. The DNA carrying two loci that are 
homologous to the loci around the DSB and flank an insert can be injected into the cell, thus, 
causing the insert to be incorporated into the repaired host DNA. 
 
FIGURE 3.3: DSB repair. Left: HDR. The process is initiated by end resection, involving the 
RAD51/RPA complex and the nuclease. Single-stranded DNA is bound by RPA, which is later replaced 
by RAD51. The latter promotes the invasion of the single-stranded DNA into the double-stranded 
homologous DNA, leading to novel DNA synthesis, strand dissolution, and repair. Many other proteins 
involved in these processes are not shown for simplicity (see [LANS ET AL. 2012] for details). Right: 
NHEJ. The broken ends are bound by Ku70/Ku80 heterodimer, which recruits and orchestrates other 
repair factors including the MNR complex. The ends are processed by a nuclease and finally ligated. 
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The latter mechanism is also referred to as illegitimate recombination or non-homologous 
end joining (NHEJ) [MOORE ET AL. 1996; BOULTON ET AL. 1996; GUIROUILH-BARBAT ET AL. 2004] 
and often requires trimming of the DNA before the two broken ends can be ligated and, 
thus, induces small-scale mutations (deletions or insertions) [WILSON ET AL. 1999; MA ET AL. 
2002]. 
If such mutations occur in the coding portion of the gene they may cause frame-shift 
mutations that lead to a loss-of-function of the encoded protein. Therefore, NHEJ is used to 
create a gene knock-out. Since the NHEJ cannot discriminate between the proper ends of 
the same original DNA molecule and any other piece of double-stranded DNA, it can be used 
to create a knock-in by providing a non-homologous piece of linearized DNA in excess, 
which may erroneously be integrated into the locus being repaired [AUER ET AL. 2014]. If the 
knock-in occurs within the coding portion of the gene it can, similar to the regular NHEJ, 
cause frame-shift mutations and, therefore, depending on the design of the particular 
construct, is often accompanied by the knock-out of the target gene. 
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3.2 MATERIALS AND METHODS 
3.2.1 INTERSPECIFIC COMPARISONS 
As mentioned above I aimed to identify salamander-specific transcripts that are likely to be 
implicated in regeneration. In order to identify homologous transcripts in the axolotl and the 
newt, I blasted the transcriptomes of both species (tblastx) against each other and only 
considered reciprocally best hits as true hits. I excluded all transcripts that were annotated in 
either species and only focused on those that had a predicted ORF in the axolotl, no 
homologs outside of the salamander lineage and were differentially expressed in the axolotl 
during the third phase of regeneration (see 3.1 Introduction). To this end I used the 
microarray data from the previous study [KNAPP ET AL. 2013]. 
While I identified approximately 15,000 transcripts that were reciprocally best homologs 
between the axolotl and newt, only about 200 were not annotated in either species and had 
the microarray expression data. Subsequently, I manually looked through the expression 
profiles of those transcripts in the axolotl and identified one candidate I later focused on. The 
criteria were that i) the axolotl contig had to have a valid – i.e. with both the start and a 
proper terminal codon - long ORF of at least 300bp; ii) the expression had to be low in 
mature tissue, but high at some time point during the third phase of regeneration process; 
and iii) the expression in the wound healing sample had to be significantly lower than that in 
the regenerating sample. In total I identified 23 transcripts that had profiles that fulfilled the 
criteria, 3 of which were significantly up-regulated in the regenerating sample. One of them 
had a particularly interesting profile similar to those of Ffg8 and HoxA-genes, which are 
known to be implicated in regeneration. 
 
 
3.2.2 TRANSGENIC ANIMALS: KNOCK-IN AND KNOCK-OUT 
In order to study the function of the identified candidate in regeneration I decided to apply 
CRISPR/Cas technique that recently also became available for the axolotl [FEI ET AL. 2014] to 
knock-out the candidate gene.  
I first aligned the transcript sequence to the homologous genomic PacBio reads to resolve 
the sequence and the structure of the underlying gene and then used an online tool ZiFiT 
(http://zifit.partners.org/ZiFiT/) to design three guide RNAs (gRNAs) targeting three different 
loci within the gene. For each gRNA two partially complementary oligos (see 3.2.7 DNA 
Constructs and Primers) were designed such that when hybridized they generate a piece 
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of double-stranded DNA with two distinct overhangs 5’-CCTA-3’ and 3’-AAAC-5’. The DNA 
fragment was subsequently ligated into a DR274 vector, which was digested using the BsaI 
enzyme exposing two complementary overhangs – 5’-TTTG-3’ and 3’-GGAT-5’, respectively 
(FIGURE 3.4). 
 
FIGURE 3.4: DR274 ligation site. The sequence between two BsaI restriction sites forms the 
prospective gRNA sequence. 
The ligated product was transfected into bacteria and the bacteria were plated onto a 
lysogeny broth (LB) plate containing kanamycin as selection marker. Finally, I validated the 
sequences of the plasmids by the Sanger sequencing. 
To create knock-out animals the gRNAs were in vitro transcribed using the T7 RNA 
polymerase, since the DR274 vector contains the T7 promoter sequence, and injected along 
with either Cas9 mRNA or CAS9 protein into the embryos at the single-cell stage. 
Since I aimed to find a novel salamander-specific protein-coding gene, it was necessary to 
proof that the candidate transcript was translated. To this end I took advantage of the 
homology-independent mode of double strand break repair (see 3.1.1 CRISPR/Cas System) 
and injected a plasmid carrying a partial green fluorescent protein (GFP) [TSIEN 1998] 
sequence as bait followed by the red fluorescent protein (RFP) sequence (FIGURE 3.5) along 
with one of the gRNAs against the transcript of interest, the gRNA against the GFP 
sequence and the CAS9 protein into the embryos at the single-cell stage. This created 
double strand breaks in both, the host DNA and the plasmid, thus, generating a piece of 
linearized DNA, which was subsequently integrated into the host genome. At a low 
frequency the integration occured in-frame such that the reporter RFP was translated and 
could be used as marker for screening. 
I examined the injected animals under the fluorescent dissecting microscope to identify 
cases of successful integration of the RFP. The RFP coding sequence was followed by a 
polyadenylation signal in the 3’ untranslated region (UTR), therefore, the knock-out of the 
target gene resulting from the knock-in was complete, as the portion of the target gene ORF 
following the RFP coding sequence could never be translated. 
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FIGURE 3.5: Structure of the knock-in plasmid. The plasmid contains a partial coding sequence of 
the GFP (green) followed by the coding sequence of the RFP (red). The GFP sequence contains a 
locus targeted by gRNAGFP (flash). Upon CAS9-mediated cleavage the plasmid is linearized and can be 
incorporated into the host genome. 
 
 
3.2.3 GENOTYPING 
For genotyping, a small piece of the tail was cut and put into the mixture of extraction 
solution and tissue preparation solution (both Sigma) according to the manufacturer protocol. 
The samples were kept for 10mins at room temperature, then put for 3mins into 95°C heat 
block. Finally, 50µl of neutralization solution (Sigma) were added to the samples. 
Afterwards, the PCR was carried out using the genotyping primers (see 3.2.7 DNA 
Constructs and Primers). 9µl of PCR product were mixed with 1µl of 100mM EDTA, heated 
to 95°C in the PCR machine and slowly cooled down to 25°C (0.1°/s). This procedure caused 
the denaturation of the DNA and the subsequent re-annealing of the DNA fragments. Finally, 
the product was run on a 6% polyacrylamide gel (PAGE). 
The denaturing and re-annealing steps yielded three different duplexes of the PCR 
fragments (FIGURE 3.6): i) if both fragments did not have any mutations, they formed a 
normal double-stranded fragment of the expected size, i.e. the distance between the two 
genotyping primers; ii) if one of the fragments carried a modification caused by the 
CRISPR/Cas, a bubble was formed in the duplex that influenced the mobility thereof; and iii) 
if both fragments carried mutations, they either formed a shorter double-stranded fragment 
(if they carried identical mutations) or formed a bubble with different mobility properties. 
After running the gel with the PCR product from wild-type non-injected animals as control 
one could easily identify animals that had mutations as their PCR products generated 
multiple bands on the gel. 
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FIGURE 3.6: Genotyping. The PCR products (green is wiltype allele, red and yellow are modifications) 
are denatured, allowed to re-anneal and run on acrylamide gel. If both strands of a newly formed 
double-stranded DNA carry no modification, a single wiltype-like band is present. Otherwise, multiple 
bands are present or a single band, if both alleles are mutated. However, this band is different from 
the wildtype band. For simplicity, all combinations are depicted separately, although in reality they are 
often present in the mixture and produce multiple bands. 
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3.2.4 PROTOCOLS 
3.2.4.1 IMMUNOHISTOCHEMISTRY STAINING 
Axolotl embryos at different developmental stages (early, mid- and late limb bud) were fixed 
for 4h in MEMFA, rinsed 3x10mins in PBS, equilibrated over night in 30% sucrose at 4°C, 
and frozen in OCT (Sakura Finetek) in desired position for cryosectioning. The sections were 
mounted on adhesive glass slides (SuperFrost Ultra Plus, Thermo Scientific), dried for 
several hours at room temperature, and washed 3x10 mins in 0.3% PBS-Triton and then 
2x10 mins in 0.1% PBS-Triton.  
The area surrounding the sections was marked by paraffin to avoid draining of the antibody 
solution. Then, the slides were incubated in the blocking buffer for 1h at room temperature. 
Afterwards, primary antibodies were added in their respective dilutions into the blocking 
buffer (250µl per slide) and incubated in humidified chambers for 2-4h at 37°C. 
Finally, the slides were rinsed 3x10 mins in 0.1%-PBS-Triton, and 500µl of secondary 
antibodies were applied and incubated for 2h at room temperature in a humidified chamber. 
After incubation the slides were washed 3x10 mins in 0.1% PBS-Triton, mounted using 
VectaShield mounting medium (H-1000, Vector Labs), and sealed using the regular nail 
polish. 
 
 
3.2.4.2 IN-SITU HYBRIDIZATION 
Axolotl embryos at different developmental stages (early, mid- and late limb bud) were fixed 
for 3 days in MEMFA, rinsed 3x10mins in PBS+DEPC, dehydrated in a series of ethanol 
washes (25%, 50%, 75%, 100%, 100%) 20 mins each, and equilibrated in 100% ethanol 
over night at 4°C. 
Next day the samples were soaked 3x40 mins in xylene, washed in paraffin for 10 min, 
soaked 3x1h in paraffin, and embedded in paraffin in desired orientation. 
Afterwards, the samples were sectioned on the Microtome (Leica), mounted on adhesive 
glass slides (SuperFrost Ultra Plus, Thermo Scientific), and dried over night at 37°C. 
Finally, the slides were washed 3x10 mins in xylene, 3x10 mins in 100% ethanol and 
hybridized for 6h in hybridization buffer containing the probe (500ng/ml). After hybridization 
the slides were washed in 5xSSC buffer for 30 mins, 2x40 mins in 2xSSC buffer, and finally 
for 10 mins in 0.2xSSC buffer. Next the slides were washed in TNE (2x10 mins), treated 
with RNase (20µg/mL in TNE) for 5 mins, and washed again in TNE (2x10 mins).  
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Before applying the first antibody (anti-DIG), the slides were washed several times in MAB – 
2, 5, and 10 mins respectively, and kept in 1x blocking reagent in MAB for 45 mins. After 
that the first antibody was applied (1:5000 in 1x blocking reagent in MAB) for 1h. The 
antibody step was followed by a series of MAB washes – 2, 5, and 3x10 mins, respectively, 
followed by two AP buffer washes 10 mins each. Finally, the slides were developed using 
AP buffer with NBT/BCIP for several hours until the signal was visible. 
 
 
3.2.4.3 ALIZARIN RED / ALCIAN BLUE STAINING 
The samples were fixed in MEMFA overnight. Next morning the samples were rinsed 3x10 
mins and 3x30 mins in PBS, washed in PBS/Tween for 20 mins, and equilibrated in 25% and 
then in 50% ethanol.  
After the washing steps the samples were put into alcian blue and the staining was carried 
out for about 4h at 37°C. The samples were then washed with 60% ethanol / 40% acetic 
acid for 1h and afterwards in 95% ethanol. 
Next, the samples were washed 3x15 mins in 1% KOH and put into alizarin red for 1h. 
Finally, the samples were washed in 1% KOH and in 1%KOH/20% glycerol until the tissue 
looked clear and the solution was replaced by 25% glycerol in PBS to preserve the samples. 
 
 
3.2.5 BUFFERS 
Name Composition 
10x MEM (pH 7.4) 1M MOPS (pH 7.4), 20mM EDTA, 10mM magnesium sulfate  
(MgSO4), H2O 
0.03% benzocaine 5% 10x TBS, 5% 10x Holtfreter’s solution, 0.03% ethyl-p-
aminobenzoate, H2O 
10x Holtfreter’s solution 2.875g potassium chloride (KCl), 5.36g calcium chloride (CaCl2), 
11.125g magnesium sulfate heptahydrate (MgSO4	 7H2O), 158.4g 
sodium chloride (NaCl), H2O 
TABLE 3.1: General purpose buffers.  
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Name Composition 
Fixative (MEMFA) 1x MEM, 3.7% formaldehyde, H2O 
Cryoprotectant 30% D(+)-saccharose in PBS 
Mounting solution 50% glycerol in PBS 
PBS 1.7mM KH2PO4, 5.2mM NaH2PO4, 150mM NaCl 
Washing buffer 0.3% or 0.1% PBS-Triton-X100 
Blocking buffer 2% normal horse serum in 3% PBS-Triton-X100 
TABLE 3.2: Buffers for immunohistochemistry staining.  
 
 
Name Composition 
Fixative (MEMFA) 1x MEM, 3.7% formaldehyde, H2O 
20x SSC (pH 7.0) 3M NaCl, 300mM trisodium citrate (Na3C6H5O7) 
5x SSC 50% formamide, 5x SSC, 0.1% tween (10%), H2O 
2x SSC 50% formamide, 2x SSC, 0.1% tween (10%), H2O 
0.2x SSC 50% formamide, 0.2x SSC, 0.1% tween (10%), H2O 
MAB (pH 7.5) 10mM maleic acid, 150mM NaCl, 150mM NaOH, 0.1% tween 
(10%), H2O 
Tris (pH 9.5 or 7.5) 1M Tris (Tris base, Trizma base, C4H11NO3), 37% HCl, H2O 
TNE 10mM Tris (pH 7.5), 500mM NaCl, 1mM EDTA 
10x blocking reagent 50g blocking reagent in 500ml MAB 
Alkaline phosphatase 
buffer (AP buffer) 
100mM Tris (pH 9.5), 50mM MgCl2, 100mM NaCl, 0.1% tween 
(10%), H2O 
Hybridization buffer 50% formamide, 10% dextran, 5x SSC, 0.1% Tween (10%), 1 
mg/ml yeast RBA, 100 µg/ml heparin, 1x Denhardt’s, 0.1% 
CHAPS, 5 mM EDTA 
TABLE 3.3: Buffers for in-situ hybridization.  
 
 
Name Composition 
Fixative (MEMFA) 1x MEM, 3.7% formaldehyde, H2O 
Alcian blue 60% ethanol (100%), 40% glacial acid, 9% alcian blue  
Alizarin red 1% KOH, 30% alizarin red, H2O 
Ethanol/Acetic acid 70% ethanol (100%), 30% acetic acid 
TABLE 3.4: Buffers for alizarin red/alcian blue staining.  
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3.2.6 ANTIBODIES 
 Antigen Host species Description Supplier 
 PRRX1 (axolotl) Rabbit Anti-rabbit Custom-made 
HOXA9 (axolotl) Rabbit Anti-rabbit Custom-made 
HOXA11 (axolotl) Mouse Anti-mouse MPI CBG 
HOXA13 (axolotl) Rabbit Anti-rabbit Custom-made 
MEIS (mouse) Mouse Anti-mouse Millipore 
 Rabbit IgG Goat Alexa 568 Invitrogen 
Mouse IgG Donkey Alexa 488 Invitrogen 
TABLE 3.5: List of antibodies. n primary, n secondary.  
 
 
3.2.7 DNA CONSTRUCTS AND PRIMERS 
 Name Application Sequence (3’ – 5’) 
 SP6 PCR ATTTAGGTGACACTATAGAA 
T7 PCR TAATACGACTCACTATAGGG 
M13fwd PCR, sequencing CCCAGTCACGACGTTGTAAAACG 
M13rev PCR, sequencing AGCGGATAACAATTTCACACAGG 
 Can1_gt_F1 Genotyping TTCCTTGCCACTGCAGCTCGTC 
Can1_gt_R1 Genotyping CTCTCGAAGCATTCACTGAAGTTGG 
Can1_gt_F2 Genotyping TGTCTGTATAGGTACACGTGTGATTTTC 
Can1_gt_R2 Genotyping GATGATCTTCAGACTCTTTCTCGG 
 Can1_Crispr_1A gRNA-1 sense oligo TAGGTTAAGAGTTACCTTGACG 
Can1_Crispr_1AS gRNA-1 antisense oligo AAACCGTCAAGGTAACTCTTAA 
Can1_Crispr_2A gRNA-2 sense oligo TAGGCCGACCATAAGGAAGAGA 
Can1_Crispr_2AS gRNA-2 antisense oligo AAACTCTCTTCCTTATGGTCGG 
Can1_Crispr_3A gRNA-3 sense oligo TAGGAAGCCGAGACGACAAAGG 
Can1_Crispr_3AS gRNA-3 antisense oligo AAACCCTTTGTCGTCTCGGCTT 
TABLE 3.6: List of primers. The primers for different purposes are grouped together n PCR and 
general-purpose primers, n animals genotyping, n gRNA oligos.  
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 Name Target Sequence (3’ – 5’) 
 Can1_4142 Candidate gene CGGTCCGGAATTTTTGGGATGCGACTCGTCTTAGGCTTTGATCGCCCGAAGAG
AATCCAACATCCTCTTTGTGTCCGTATCTCAGAAACCCCGCCATGGCAGACGC
AGCAGTGGAGAACGCAGTCGCTCCCGCCGAGTCCCCCGTCAAGGACCTCAAAG
AAAAGAAAGAAGTTGTAGAAGAACCAGCGAAAGAAAAGGCTGAGAACGGAAGC
GGAGACGCACCCGCGAATGGAACAGAAGAAAATGGGGCCGACCATAAGGAAGA
GAAGGTAAAGGAAGCCGAGACGACAAAGGAGGAGGTGAAAGAGCCCGAGCCTG
CCGCAGAGAAGACGGAGAAGACTGACGAGGCCGATGGTGGCGAAGAGAAGAAG
GATGCCGAGAAAGAGTCTGAAGATCATCCTGTAAAACGTCCTGCAGAAGAAGA
GGAGAAAGTCGAAACTAAAAAACAGAAGACCGAGAATGGCGATTCGACAGAAG
TGGAAGCATCGGCTTAGTCAATTGTACAACTTTTTTTATAGCTTAAGTGACAT
GGTTGATATTAATTCGTAGAGGATGTGCTTTATATCTGTACATTTTACAGACC
AACTTTTTTATAAACTGTAAACTCACATGCACTAGAGACGTAACATCACAGCA
AGATAGCAACGTTTTTTTTGTAAAATGTTATTTATTGGTGCGTGTTTGTACTG
GTTGACTGCTACAATTTAAAAAAAACAAACTTGTTTTTGAGTGGTGGTTTTAG
CTTTGCTTTTTGTACATCTTTGAAGCACATGCCTTATGTTTCCGTACAGCCAT
GTGTTTCCTTTAGTAAAGCTGCCCTTCCT 
 
Can1_4166 Candidate gene GCTCTTGCGAACCTCGTCTTAGGCTTTGATCGCCCGAAGAGAATCCAACATCC
TCTTTGTGTCCGTATCTCAGAAACCCCGCCATGGCAGACGCAGCAGTGGAGAA
CGCATGTCGCTCCCGCCGAGTCCCCCGTCAAGGACCTCAAAGAAAAGAAAGAA
GTTGTAGAAGAACCAGCGAAAGAAAAGGCTGAGAACGGAAGCGGAGACGCACC
CGCGAATGGAACAGAAGAAAATGGGGCCGACCATAAGGAAGAGAAGGTAAAGG
AAGCCGAGACGACAAAGGAGGAGGTGAAAGAGCCCGAGCCTGCCGCAGAGAAG
ACGGAGAAGACTGACGAGGCCGATGGTGGCGAAGAGAAGAAGGATGCCGAGAA
AGAGTCTGAAGATCATCCTGTAAAACGTCCTGCAGAAGAAGAGGAGAAAGTCG
AAACTAAAAAACAGAAGACCGAGAATGGCGATTCGACAGAAGTGGAAGCATCG
GCTTAGTCAATTGTACAACTTTTTTTATAGCTTAAGTGACATGGTTGATATTA
ATTTCGTAGAGGATGTGCTTTTATATCTGTACATTTTACAGACCAACTTTTTT
ATAAACTGTAAACTCACATGCACTAGAGACGTACATCACAGCAGATAGCAACG 
 
 FGF8_DK Fgf8 TCACGTGCCTCACCTCCACTACCTCAGCAGCAGGCTGTGCGAGGGTCTGTAGG
TGCTCGCCCTTGGGACCCTTGCATCTTGCCTGCGGCCCGTGATCCAAGGTGGC
AATGTTGCCACTAAGCTAGTGCTTCGCAGAGGAGACACGCGTGGAAGCGGTTT
ATGCAGAACAGGGGTGCTACTGGAGGACAGGCGCTTTATGCCGGGTAACGATC
CGTAAAGCGCCCTTCGGGGACTTCCCATTTGCAGACAAGACATCGCTCCAGCA
AGGGGTTTATTCACGGGCAGCAGCGCTTCTGCGAGCGATCTAGAGAGAGCCAC
GCCAAGGTGGGACAGCCGAACTCCCGAGCCCCTGCCATCGAACTCATCCCACG
GGTTAAGCCCTGCGAGCGATAAACCGCTCTCTACCCGCCGGCCAGAGCGGTCC
GAAGGGTTCAGAATGAACAACGCGAGCTCGTCAGTCGTCGGATATCTATTGCT
GCATCTTTTTGTCCTCTGCATGCAAGCAAAGGTAACTGTTCAGTCCCCACCTA
ATTTTACACAGCATGTGAGGGAGCAGAGCCTGGTGACAGACCAGCTGAGCCGG
CGGCTCATCCGCACCTACCAGCTGTACAGCCGCACCAGTGGGAAGCACGTGCA
GGTCCTTGGCAACAAGAAGATCAACGCCATGGCCGACGACGGCGACTCGCACG
CCAAATTAATTGTGGAAACGGACACCTTCGGAAGCCGCGTCCGCATTAAAGGA
GCCGAGACGGGCTATTACATCTGCATGAACAAGAAGGGAAAGCTGATTGGCAA
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GAGCAATGGCCGAGGCAAAGACTGCGTCTTCTCCGAGATAGTGCTCGAGAACA
ACTACACGGCACTACAAAACGCCAAATACGAAGGATGGTACATGGCCTTCACA
AGGAAAGGCCGCCCGAGGAAAGGCTCCAAGACCAGGCAGCACCAGCGGGAGGT
CCACTTCATGAAGCGACTGCCGAAAGGCCACCAAACAACGGAGCCTCATAGAC
GCTTCGAGTTTGTAAATTATCCTTTCAACAGGCGGAGCAAAAGAACTCGACAT
TCCGTACCGCGATAGGAACCAAAACACTCCTCAGC 
 
FGF8_EN Fgf8 CACGTGCCTCACCTCCACTACCTCAGCAGCAGGCTGTGCGAGGGTCTGTAGGT
GCTCGCCCTTGGGACCCTTGCATCTTGCCTGCGGCCCGTGATCCAAGGTGGCA
ATGTTGCCACTAAGCTAGTGCTTCGCAGAGGAGACACGCGTGGAAGCGGTTTA
TGCAGAACAGGGGTGCTACTGGAGGACAGGCGCTTTATGCCGGGTAACGATCC
GTAAAGCGCCCTTCGGGGACTTCCCATTTGCAGACAAGACATCGCTCCAGCAA
GGGGTTTATTCACGGGCAGCAGCGCTTCTGCGAGCGATCTAGAGAGAGCCACG
CCAAGGTGGGACAGCCGAACTCCCGAGCCCCTGCCATCGAACTCATCCCACGG
GTTAAGCCCTGCGAGCGATAAACCGCTCTCTACCCGCCGGCCAGAGCGGTCCG
AAGGGTTCAGAATGAACAACGCGAGCTCGTCAGTCGTCGGATATCTATTGCTG
CATCTTTTTGTCCTCTGCATGCAAGCAAAGGTAACTGTTCAGTCCCCACCTAA
TTTTACACAGCATGTGAGGGAGCAGAGCCTGGTGACAGACCAGCTGAGCCGGC
GGCTCATCCGCACCTACCAGCTGTACAGCCGCACCAGTGGGAAGCACGTGCAG
GTCCTTGGCAACAAGAAGATCAACGCCATGGCCGACGACGGCGACTCGCACGC
CAAATTAATTGTGGAAACGGACACCTTCGGAAGCCGCGTCCGCATTAAAGGAG
CCGAGACGGGCTATTACATCTGCATGAACAAGAAGGGAAAGCTGATTGGCAAG
AGCAATGGCCGAGGCAAAGACTGCGTCTTCTCCGAGATAGTGCTCGAGAACAA
CTACACGGCACTACAAAACGCCAAATACGAAGGATGGTACATGGCCTTCACAA
GGAAAGGCCGCCCGAGGAAAGGCTCCAAGACCAGGCAGCACCAGCGGGAGGTC
CACTTCATGAAGCGACTGCCGAAAGGCCACCAAACAACGGAGCCTCATAGACG
CTTCGAGTTTGTAAATTATCCTTTCAACAGGCGGAGCAAAAGAACTCGACATT
CCGTACCGCGATAGGAACCAAAACACTCCTCAGCGATCCACCGCCTTTTCTAC
TCCAGTGGACTTTTAGAAGAACAATT 
TABLE 3.7: List of ISH probes. The probes for different targets are grouped together n candidate 
gene, n Fgf8.  
 
 
  
	84	
3.3 RESULTS 
3.3.1 INTERSPECIFIC COMPARISON 
A large (9,042 or 19%) proportion of all transcripts had no detectable orthologs in the RefSeq 
dataset, but had predicted ORFs that were at least 100 amino acids long. That indicated that 
there could be a number of axolotl-specific transcripts, which did not have homologs in other 
vertebrates. It was tempting to ask the question whether some of those transcripts could 
represent regeneration-specific genes. Inspired by the example of the gene nAG [DA SILVA ET 
AL. 2002], which is implicated in the regeneration, I decided to perform an interspecific 
comparative genomics analysis to identify novel transcripts that, nevertheless, have 
orthologs in the newt. 
To this end I first blasted the entire axolotl transcriptome against the two newt 
transcriptome assemblies [ABDULLAYEV ET AL. 2013; LOOSO ET AL. 2013] (tblastx, e-value cut-
off 1e-30) and vice versa and limited the subsequent analyses to the contigs that were not 
annotated in either species, but were reciprocally best hits (FIGURE 3.7).  
 
FIGURE 3.7: Candidate selection. The majority of the reciprocally best hits are annotated in at least 
one species. However, 198 are not annotated in either. 
Of a total of 29,503 Blast hits between the axolotl and the newt, 14,423 were reciprocally 
best hits. However, only 96 contigs of 198, which were not annotated in either species, had 
a predicted ORF and were used analyzed further. 
In order to pick the candidates that could be implicated in regeneration I manually looked 
through the microarray time course profiles of those 96 contigs and identified several 
candidates with profiles that fulfilled the criteria listed in 3.2.1 Interspecific Comparison. 
Afterwards, I analyzed the predicted protein sequence of those candidates and tried to 
predict protein domains using InterProScan [ZDOBNOV ET AL. 2001] and SMART [SCHULTZ ET 
AL. 1998]. One of the candidates (AC_02200044868.1, subsequently referred to as candidate 
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contig) was predicted to belong to the prothymosin/parathymosin family of proteins 
(IPR004931), but only had four uncharacterized low complexity domains. The members of 
that protein family are small acidic nuclear proteins that are thought to be involved in cell 
cycle progression, proliferation and cell differentiation [VARELI ET AL. 2000]. The description of 
the putative protein function agreed well with the expected function of the candidate gene 
and the fact that there were no orthologs in non-regenerating RefSeq organisms increased 
the likelihood for the candidate to be salamander-specific.  
The alignment of the predicted protein sequence to the homologous newt sequence 
revealed that while both, the N-terminus and the C-terminus of the protein were conserved 
between the axolotl and the newt, the middle part of the protein consisting of low-
complexity domains was not (FIGURE 3.8). 
 
FIGURE 3.8: Homologous alignment to the newt. While the termini of the protein are fairly well 
conserved between the axolotl and the newt, the middle part is not. 
The transcript is highly expressed during development, but significantly down-regulated, 
although not completely shut down, in the mature limb. It remains down-regulated during 
the early stages, but is up-regulated again during the late stages of regeneration. It is 
however not up-regulated in the simple wound healing (FIGURE 3.9).  
 
FIGURE 3.9: Candidate for CRISPR/Cas knock-out. Based on the microarray data, the transcript is 
highly expressed during development and at the late stages of regeneration, but is significantly down-
regulated, although still expressed, in the mature tissue and during the early stages of regeneration. 
The microarray data testified that the candidate gene was expressed in the limb bud, but the 
exact localization of the transcription is not known. I performed an in-situ hybridization (ISH) 
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combined with the 4',6-diamidino-2-phenylindole (DAPI) staining on day 19 post injection 
(19dpi) to confirm that the candidate gene was indeed expressed in the limb bud during 
embryogenesis and to determine its expression domain. The candidate gene was expressed 
in the mesenchyme throughout the limb bud. However, it was absent from the epidermis as 
it is evident from the DAPI staining (FIGURE 3.10).  
 
FIGURE 3.10: Candidate gene expression. ISH and DAPI staining confirmed that the candidate gene 
is expressed in the mesenchyme of the wild-type limb bud, but not in the epidermis (arrowheads). 
 
 
3.3.2 CRISPR/CAS TRANSGENICS 
With the emergence of the CRISPR/Cas system, it became fairly straightforward and easy to 
create transgenic knock-out and knock-in animals to study gene function. 
Since I identified the candidate using the transcriptome data, it was necessary to determine 
the underlying gene sequence first. Otherwise the putative gRNA target site could cross the 
exon-exon boundary and, thus, be disrupted by the intron on the genome level.  
To this end I identified a set of genomic PacBio reads that had high homology to the 
candidate transcript and assembled them using CeleraAssembler (v.8.3rc2) [MYERS ET AL. 
2000]. Afterwards, I mapped the transcriptome sequence to the assembled genomic 
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sequence and corrected the alignment manually, to make sure that the introns began and 
ended with their characteristic sequences: GT and AG for the start and end of the intron, 
respectively (FIGURE 3.11) [CLANCY 2008].   
 
FIGURE 3.11: Genomic structure of the candidate gene. Bars of different colors indicate five 
different exons of the candidate gene and also show their relative positions within the PacBio read 
(top line) and the transcript from the assembly (bottom line).  
I designed 3 different guide RNAs (gRNAs) for the CRISPR/Cas-mediated knock-out. The 
gRNA-1 crossed the exon-intron boundary of exon 1 and both, gRNA-2 and gRNA-3 targeted 
exon 3. Afterwards, 20 animals at the single-cell stage were injected with the mixture of a 
respective gRNA and the Cas9 mRNA. Another 20 animals were injected with the Cas9 
mRNA only and used as controls. These 80 animals are subsequently referred to as batch 1. 
I genotyped the animals by amplifying the targeted locus by PCR using the genotyping 
primers and running the products on the acrylamide gel afterwards (see 3.2.3 Genotyping). 
All animals showed multiple bands on the gel (FIGURE 3.12, top panel), which indicated that 
an array of independent insertion or deletion events collectively termed InDels occurred due 
to the CRISPR/Cas-mediated mutagenesis. One likely explanation for such mosaic pattern 
was that the double strand breaks were introduced at the multicellular stage, because it took 
certain amount of time until CAS9 protein was translated.  
In order to evaluate the types of modifications I selected several animals, e.g. animal 5 in 
FIGURE 3.12, and cloned the PCR products into the bacteria that were subsequently plated 
and formed colonies. Each colony only contained clones of a single original PCR product. 
Afterwards, I randomly picked 8 colonies that belonged to the same animal, extracted DNA 
and sequenced it by the Sanger sequencing using the genotyping primers.  
The sequencing results in FIGURE 3.12, bottom panel showed multiple sequence alignment 
of the sequences coming from those 8 colonies and, therefore, confirmed the presence of 
the multiple different deletions in the targeted locus. The longest modification extended into 
the intron, thus, removing the exon-intron junction and altering the coding sequence. 
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FIGURE 3.12: Genotyping results of gRNA-1 batch. Top. Multiple bands are indicative of multiple 
modifications caused by the CRISPR/Cas. Compare to the single bands in the control samples. 
Bottom. The DNA of the animal with multiple modifications was used for sequencing in order to 
resolve modifications. The amplified DNA from the modified locus was cloned and sequenced 
revealing multiple modifications. The locus targeted by the gRNA-1 is shaded in blue.  
Although the ISH and DAPI staining confirmed that the candidate gene was expressed, it 
was necessary to show that it was protein-coding. Since the gene was novel, there was no 
antibody against the presumable protein. Together with Dr. Ji-Feng Fei who established the 
CRISPR/Cas system in the axolotl we created knock-in animals, in which the coding 
sequence of the reporter RFP gene was knocked into the locus of the candidate gene. 
Parallel to the knock-out experiment, 22 animals were injected with the gRNA-1, plasmid 
containing RFP reporter gene, gRNA against the GFP and CAS9 protein (see 3.2.2 
Transgenic Animals: Knock-in and Knock-out). The integration of the polyadenylated RFP 
sequence also prevented the candidate gene from being translated beyond the position of 
the integration, thus, generating a target gene knock-out. Since there was only one out of 
three chances for the integration to occur in-frame, the efficiency of the knock-in was 
relatively low. Only a single animal had an insertion of the RFP reporter gene afterwards. 
Luckily, in contrast to the knock-out, the insertion occurred at the two-cell stage. One likely 
explanation is that due to the fact that the CAS9 protein was used instead of the Cas9 
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mRNA, there was no translation-induced time delay. The right half of the animal was normal 
and the left half was transgenic (FIGURE 3.13).  
 
FIGURE 3.13: Knock-in animal on 18dpi. While the left half of the animal was transgenic, the right 
half was likely to consist of unmodified cells. RFP was expressed in the limb bud (white arrowhead) 
and in the brain (yellow arrowhead). 
The RFP reporter gene was highly expressed in the developing limb bud and also in the 
brain. It was also very weakly expressed in the tail (data not shown).  
There were three possibilities that would produce such phenotype: i) RFP was integrated in 
both, the maternal and the paternal alleles of the candidate gene, thus, generating a 
homogeneous knock-out; ii) only one of the two alleles had a knock-in, while the other 
carried an indel potentially leading to a knock-out (if it caused a frame-shift); and iii) 
alternatively, apart from a knock-in allele, the remaining allele was intact, in which case the 
left side of the animal was heterogeneous and the candidate gene expression was knocked 
down, but not completely eliminated. To discriminate between those three possibilities I let 
the animal grow until 142dpi and amputated both limbs to see if there were differences in 
regeneration similar to those in development (see below). The amputated limbs were used 
for IHC staining (see 3.4 Discussion). Additionally, I also collected one digit from each limb 
for genotyping. 
The half transgenic animal offered a unique possibility to compare the development of the 
wild-type and mutant limbs in the same animal. I imaged the animal at several different time 
points to follow the development of the limbs (FIGURE 3.14). 
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It is apparent that the mutant limb developed significantly slower than the contralateral wild-
type limb. The delay was approximately 8 days, as on day 26 post injection the right limb 
roughly corresponded in size to the contralateral limb on 18dpi. However, already by 49dpi 
both limbs were approximately of the same size.  
The expression pattern of the RFP reporter gene on 18dpi resembled that of the candidate 
gene in the wild-type animal on 19dpi as was demonstrated by the ISH. 
 
FIGURE 3.14: Development time-course (ventral view). The mutant limb bud (red) was significantly 
delayed in development. By 44dpi it caught up in size with the contralateral wild-type limb. 
By 142dpi the left limb of the animal was still expressing RFP, while the intensity of the 
expression was significantly lower than at the earlier stages (FIGURE 3.15). This observation 
was consistent with the microarray time-course profile of the candidate gene. Genotyping of 
both limbs should answer the question whether the knock-in was homozygous or 
heterozygous.  
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FIGURE 3.15: Knock-in animal on 142dpi. The expression of the RFP in the left limb was 
significantly weaker than before. The contralateral limb showed no RFP expression. The long and 
short lines indicate amputation planes for the IHC and genotyping, respectively. 
The ISH and knock-in confirmed that the candidate gene was expressed throughout the limb 
bud during embryogenesis and that it is protein-coding. At later time points, e.g. 49dpi and 
62dpi, it was also evident that the expression of the RFP reporter was down-regulated. This 
finding was in close agreement with the microarray time course profile, which demonstrated 
that the candidate gene was down-regulated, but not inactivated completely. 
Since axolotls can regenerate both, the limb and the tail, it was tempting to investigate the 
role of the candidate gene in the tail regeneration. 
While there were no microarray time course data of the wounded tails, there were data of a 
tail amputation experiment [Nacu, unpublished] (FIGURE 3.16). 
 
FIGURE 3.16: Tail regeneration time-course. The candidate gene is up-regulated in a more steep 
fashion and reaches the maximum on 5dpa/120hpa. 
Those data also demonstrated that the candidate gene was implicated in the process of 
regeneration as it was up-regulated during regeneration. In contrast, in the tail the up-
regulation was steeper and reached the maximum earlier than in the limb regeneration. 
However, since those were two different experiments that were carried out using the 
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animals of different sizes, the differences in up-regulation could possibly be caused by 
different experimental conditions.  
The data of both experiments were consistent and demonstrated that the candidate gene 
was up-regulated in the limb and tail regeneration. 
With this knowledge I decided to investigate the impact of the candidate gene knock-out on 
the regeneration. Based on the timing of the up-regulation in both, the tail and the limb 
regeneration time-course experiments, I let the animals of the batch 1 grow to the size of 
5cm from snout to tail and then amputated the right forelimb at three different levels: i) 
through the wrist; ii) through the elbow; and iii) close to the shoulder. I also amputated the 
distal quarter of the tails of the same animals to see if the impact on regeneration was 
different in the tail and in the limb. 
The regenerating limbs were imaged every 5 days and the tails every 7 days in order to track 
the regeneration process. Other than anticipated based on the developmental phenotype of 
the knock-in animal, the majority of the injected animals did not show any differences in 
regeneration speed or patterning to the wild-type controls (FIGURE 3.17).  
 
FIGURE 3.17: Limb regeneration on 20dpa. The limbs were amputated at three different levels: 
wrist, elbow, and shoulder. However, no significant differences were observed between the mutant 
and the control animals. The body axes (A – anterior, P – posterior) also regenerate normally in all 
cases. 
This could be due to a lower efficiency of Cas9 mRNA, which was injected in the animals of 
the batch 1, versus CAS9 protein used to create the knock-in animal.  
While the process of regeneration in the majority of the injected animals was 
indistinguishable from that in the uninjected controls, a few injected animals showed mild 
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delays in regeneration on 20dpa (FIGURE 3.18). Nevertheless, no significant correlation 
between those delays and the genotyping results could be found. 
 
FIGURE 3.18: Delayed regeneration on 20dpa. Left panel shows an example of the delayed 
regeneration compared to the wild-type sibling in the right panel. It is apparent that while the control 
limb already started patterning, the limb of the transgenic animal did not. 
The regenerated limbs were collected after the regeneration was complete and stained for 
the bone and cartilage using Alizarin red / Alcian blue staining (see 3.2.4.3 Alizarin 
Red/Alcian blue staining). The staining did not reveal any differences between the 
transgenic and control animals, either (data not shown). 
The situation was slightly different in the tail regeneration. Several animals exhibited 
significantly delayed tail regeneration (FIGURE 3.19). Nevertheless, the affected tails caught 
up with the normal tails several days later, and no patterning differences could be identified 
afterwards. 
 
FIGURE 3.19: Tail regeneration time-course. The tails of a few mutant animals were significantly 
delayed compared to the control animals. Black arrow indicates the dorso-ventral orientation of the 
images. 
	94	
An interesting observation was made in the developing animals before amputation. The 
myotomes of several animals including the ones that later exhibited the delays in the tail 
regeneration were disorganized compared to those of the control animals (FIGURE 3.20). 
However, the tail regeneration in some of the animals with disorganized myotomes was not 
delayed. 
 
FIGURE 3.20: Abnormal myotome structure. The tails of the animals with delayed tail regeneration 
have disorganized myotomes before amputation (red arrow heads). The orientation of all images is 
the same. 
Intriguingly, the animals that exhibited delays in the tail regeneration were different than 
those with delays in the limb regeneration. It was not possible to correlate the phenotype 
with the genotype of those animals, either. 
To confirm the findings and to get a larger population of mutants in order to increase 
statistical significance, I decided to inject more animals and to screen for putative mutants 
early in the development using the delayed limb bud development as the phenotypic marker. 
Unfortunately, the expression of the RFP in the tail of the knock-in animal was difficult to 
evaluate because the tail had abnormal morphology. Therefore, I did not have a screening 
marker for the putative mutants with the candidate gene knock-out in the tail. 
For this reason I only focused on the animals that had delayed limb bud development 
phenotype.  
The animals of the second batch (batch 2) were injected with the three gRNAs (100-120 
animals per gRNA) and the CAS9 protein instead of the Cas9 mRNA in order to increase 
efficiency and avoid delays caused by the Cas9 mRNA translation. I screened the animals on 
19dpi for developmental delays (FIGURE 3.21). A number of animals exhibited the phenotype 
similar to that observed in the knock-in animal (TABLE 3.8). 
gRNA Total number Mutants Controls 
gRNA-1 115 21 14 
gRNA-2 91 10 12 
gRNA-3 79 9 18 
TABLE 3.8: Overview of the second injection batch.  
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FIGURE 3.21: Knock-out animal with clear phenotype on 19dpi. The left panel shows the wild-type 
animal on day 19 post injection, whereas the right panel shows an example of the animal with 
delayed development. Note the difference in size of the limb buds. 
After the initial screening I only kept the controls and the mutants that exhibited a clear 
phenotype. I traced the development of the animals from 19dpi through 43dpi (FIGURE 3.22).  
Different limbs of the same animal also exhibited different developmental speed as can be 
seen in FIGURE 3.22a. Both limb buds of the animal in the figure were affected as can be 
recognized on their smaller appearance on 19api in comparison to the limb buds a wild-type 
sibling. While the right limb of the modified animal was approximately 8 days delayed 
compared to the wild-type limb bud, the right limb bud was delayed by approximately 15 
days (43dpi of the injected animal looked similar to 28dpi of the uninjected sibling). To which 
extent the limb bud development was delayed in different injected animals was, therefore, 
variable and most likely depended on the ratio between the homozygous, heterozygous and 
wild-type cells constituting the respective animal or limb. 
Interestingly, similar to the knock-in animal, the affected limb buds did not stop developing 
and eventually also formed fully patterned limbs. Moreover, by 72dpi both limbs of the 
injected animal were very similar in size to each other and to the limbs of the wild-type 
sibling (FIGURE 3.23).  
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a. Transgenic animal. Ventral view. Note the differences in size between the affected limb (left) 
and the wild-type limb (right). 
 
b. Control animal. Ventral view. The both limbs develop at the similar pace. 
FIGURE 3.22: Time course of limb development in transgenic animals and controls. a. Both limb 
buds of the animal were significantly delayed compared to the wild-type control (b). Additionally, the 
left limb bud was also significantly delayed compared to the contralateral limb.  
 
FIGURE 3.23: Transgenic animals on 72dpi. Both limbs of the transgenic animal were patterned and 
looked very similar to each other and the non-injected control by day 72 post injection. 
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It was very tempting to address the question why the limb outgrowth was delayed in the 
mutants and what governed the temporal delay.  
First, I wanted to verify that the candidate gene was indeed not expressed or was 
significantly down-regulated in the limbs exhibiting delay in development. Since the early 
limb buds are difficult to see, I used the marker for connective tissue progenitor cells 
(PRRX1) as the marker for the limb bud [PRAYAG MURAWALA unpublished] and performed a 
combined in situ hybridization (ISH) and immunohistochemistry staining (IHC) on the same 
slide. Although PRRX1 was present in the delayed limb buds, the candidate gene was not 
expressed (FIGURE 3.24). 
In the subsequent images I use the following abbreviation convention: the arrows always 
indicate the directions of the axes, while the proximo-distal and anterio-posterior axes are 
abbreviated as P-D and A-P, respectively.  
Compared to the wild-type control limb bud, the expression of the candidate gene could not 
be detected by the ISH in the limb bud of the injected animal. While both, the DAPI and 
PRRX1 IHC stainings labeled cells quite some cells in the section, neither of them seemed 
to express the candidate gene. It suggested that both alleles of the candidate gene were 
knocked-out in the injected animal.  
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FIGURE 3.24: Candidate gene knock-out. DAPI stains the nuclei of all cells. PRRX1 is the marker of 
connective tissue progenitor cells. ISH shows no candidate gene expression in the animal injected 
with the gRNA-1. In the wild-type control the candidate gene is expressed throughout the limb bud 
(ISHwt). 
 
In both, the limb development and regeneration (see 1.2.1 Limb Regeneration) the 
outgrowth of the limb bud depends on the signaling between its mesenchyme and the FGF8 
secreted by the AER and AEC, respectively [ZELLER 2010; BUTTERFIELD ET AL. 2010]. Since 
the in situ results in the wild-type animals indicated that the candidate gene was expressed 
in the mesenchyme of the limb bud, it was straightforward to check whether FGF8 was 
expressed in the limbs of the animals showing delayed limb bud development as a 
consequence of the CRISPR/Cas-mediated knock-out. The Fgf8 time-course profile looks 
similar to that of the candidate gene. They both are highly expressed during the embryonic 
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development, down-regulated in the mature limb and up-regulated again on 12dpa in the 
regenerating, but not in the wounded sample (FIGURE 3.25). 
 
FIGURE 3.25: Time-course profile of Fgf8. The time-course profile of Fgf8 resembles that of the 
candidate gene. 
To this end I performed a combined ISH and IHC with the Fgf8 mRNA and the PRRX1 
antibody, respectively. Normal pattern of the Ffg8 expression at the distal tip of both, the 
wild-type and the mutant animals (FIGURE 3.26) was not influenced by the knock-out or the 
knock-down of the candidate gene. The expression pattern was consistent in all analyzed 
animals and the domain of Fgf8 expression seemed to scale with the size of the respective 
limb bud. Since the mutant limb bud was smaller than that of the wild-type sibling I took an 
ISH image of the Fgf8 expression pattern at an earlier developmental stage [ELENA 
GROMBERG unpublished], which roughly corresponded to the mutant limb bud size wise. The 
spatial domain of the Fgf8 expression was very similar to that of the limb bud of the injected 
animal. 
From those findings I concluded that while the candidate gene knock-out was successful, 
the Fgf8 expression was not impaired or altered and, therefore, not causative for the 
developmental delay. 
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FIGURE 3.26: Fgf8 expression in knock-out animals. DAPI stains the nuclei of all cells. PRRX1 is the 
marker of connective tissue. The Fgf8 expression is apparent at the distal tip of the limb bud in both, 
the knock-out animal (red arrow) and the control wild-type animals at different developmental stages 
(ISHwt, red and green arrows). 
It was shown that the vertebrate homeobox containing transcription factors (Hox genes) are 
important for patterning of the primary and secondary axes of the developing embryo 
[NELSON ET AL. 1996]. These genes are organized in four clusters (Hoxa-Hoxd). All Hox-genes 
have specific domains of expression along the axis of the embryo [KESSEL ET AL. 1990B; 
KESSEL ET AL. 1990A]. Therefore, the Hox-genes define territories of the growing limb [ZELLER 
ET AL. 2009; ZELLER 2010]. Since the patterning of the limb buds was delayed, it was 
straightforward to check the expression of HOXA9, HOXA11 and HOXA13 that define the 
upper and the lower arm, and the hand, respectively. There were two possible explanations 
for the phenotype observed in the delayed limb buds: i) the domains specified by the HoxA 
genes appear normally, but are smaller leading to a smaller limb bud size; ii) some or all of 
the HOXA domains fail to appear.  
The time-course profiles of HoxA9, HoxA11 and HoxA13 looked similar to that of the 
candidate gene (FIGURE 3.27). 
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a. HoxA9.  
 
b. HoxA11.  
 
c. HoxA13.  
FIGURE 3.27. Time course profiles of the HoxA genes. All HoxA genes seem to have the 
expression profiles that resemble that of the candidate gene, thus, suggesting that they might be 
interacting or involved in the same cellular process. 
To check those hypotheses, I fixed some of the mutant animals, their uninjected siblings 
and wild-type animals that had limb buds of approximately the same size as mutant animals 
(FIGURE 3.28) for IHC staining in order to check for HOXA9, HOXA11, and HOXA13 domains 
in the upper arm, lower arm and hand, respectively. Since HOXA9 is not a very good marker 
of the upper arm identity at the early developmental stages, I additionally used MEIS2 
[OULAD-ABDELGHANI ET AL. 1997] as a marker for the upper arm identity. 
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FIGURE 3.28. IHC results. As expected, PRRX1 was expressed at the distal end of the limb bud 
(indicated by the red arrowheads in wild-type size match), MEIS labeled the upper arm, HOXA9 and 
HOXA11 labeled the lower arm and HOXA13 was expressed at the very tip of the wild-type limb bud 
(red arrowhead). However, HOXA13 was not expressed in the injected mutant limb bud (yellow 
arrowhead) and in the wild-type size match control.  
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While the MEIS domain seemed not to be affected in the mutant animal and occupied 
approximately the same spatial domains in the limb buds of both, the mutant and the wild-
type siblings, the domains of the PRRX1 and both, HOXA9 and HOXA11 seemed to be 
significantly smaller in the mutant animal than they were in the wild-type sibling control. The 
expression pattern of those genes was also different from the size matched wild-type 
animals, in which all, PRRX1, MEIS, HOXA9, and HOXA11 co-localized at that developmental 
stage. 
In the mutant animal, however, the HOXA13 domain was missing completely. It resembled 
the situation in the size matched wild-type limb bud, where HOXA13 expression was also 
absent.  
Luckily, while the left limb bud of the analyzed injected animal showed evidence for 
developmental delay, the right limb bud looked normal. This offered a unique chance to 
compare the expression patterns of the genes in the delayed and normal limb buds of the 
same animal.  
The patterns of expression of all marker genes in the contralateral limb bud were very similar 
to those in the wild-type sibling (FIGURE 3.29). 
 
FIGURE 3.29. IHC results in the contralateral limb of the injected animal. The patterns of 
expression of PRRX1 and HOXA9-13 are similar to those in the wild-type limb bud. 
This observation led to the conclusion that the potential to express HOXA13 was not 
impaired in the mutant animal, but the affected limb bud of the mutant animal did not reach 
the developmental stage and size, at which HOXA13 starts to be expressed normally 
[ROENSCH ET AL. 2013]. Due to large variation in size of the limb buds between the mutant 
animals, the limb bud that was sectioned and used for IHC was also slightly larger than the 
limb bud of the size-matched wild-type control animal. Despite the size difference, the 
expression patterns of HOXA9-13 were very similar in both, the mutated limb bud and the 
size-matched control. This observation suggested that developmentally the mutated limb 
bud was closer to the size-matched wild-type limb bud than to the contralateral limb bud of 
the same animal. 
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The fact that the mutated animals eventually developed fully patterned limbs despite of the 
initial developmental delay suggested that they started to express HOXA13 later in their 
development. I confirmed this finding by performing an IHC staining using the limb bud of a 
mutant animal from the same batch, which was three days older (FIGURE 3.30). It was 
apperent that HOXA13 started to be expressed at the very tip of that limb bud. 
 
FIGURE 3.30. HOXA13 expression in an older mutant limb bud. HOXA13 starts to be expressed at 
a later time point in mutant limb bud. 
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3.4 DISCUSSION 
The question whether the species that have regenerative capacities also developed a 
specialized set of genes in the course of their evolution or whether the ability to rebuild lost 
structures is a by-product of a different biological process can to some extent be approached 
by identifying a gene that is present in regenerating, but not in the non-regenerating species 
and is up-regulated during regeneration. To this end I used a bioinformatics approach to 
compare two relatively closely related species, the Mexican axolotl and the newt that both 
have amazing regenerative abilities. 
I identified a candidate gene that was significantly up-regulated in regenerating limbs and 
tails of the axolotl and also had a homologous gene in the newt. Nonetheless, as the 
genomes and transcriptomes of more and more species get sequenced the likelihood to find 
a homologous gene in some other species constantly increases. I could, therefore, identify 
several homologs (FIGURE 3.31) of the candidate gene in the latest release of the NCBI non-
redundant (nr) database.  
 
FIGURE 3.31. Multiple sequence alignment of candidate gene homologs. Similar to the homology 
between the axolotl and the newt, the multiple protein sequence alignment reveals that the N- and C-
termini of the protein encoded by the candidate gene are more conserved than the middle part. 
Interestingly, two species that are well-known for their regenerative abilities were also 
presented on that list: the frog (Xt) and the zebrafish (Dr). Intriguingly, the literature research 
revealed that some other organisms on the list, like the Mexican cavefish (Am), Astyanax 
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mexicanus [RASQUIN 1949], the spotted gar (Lo), Lepisosteus oculatus, or the rainbow trout 
(Om), Oncorhynchus mykiss [Ingerslev 2008], are also used as the model organisms to 
study regeneration. Therefore, one could speculate that the candidate gene is indeed 
important for the regeneration, as it is only present in the regenerating species. 
Since the candidate gene belongs to the family of prothymosins/parathymosins, the 
members of which are involved in cycle progression, proliferation and cell differentiation, it is 
likely that the knock-out or knock-down of this gene could lead to cell cycle aberrations. 
Those could be responsible for the observed phenotypes in both, the developing limb buds 
and the regenerating limbs and tails of the axolotl.  
There are two possibilities how the smaller mutated limbs bud could arise: i) the modified 
cells are able to proliferate, but the cell cycle is delayed; or ii) the modified cells fail to 
proliferate.  
If the modified cells were indeed incapable of proliferation, then the respective limb buds in 
homozygous mutants would never grow. In contrast, the ISH showed no evicence of 
candidate gene expression in the mutant limb bud. That limb bud did, however, develop up 
to the size it was collected at. For this reason the second alternative can be rejected.  
While the ISH of the candidate gene knock-out did not show any detectable signal, in 
contrast, the observations made in the transgenic animal from batch 2, in which both limbs 
were delayed, but one to a lesser extent than the other (FIGURE 3.22) suggest that the effect 
of the knock-out is rather dosage dependent. Therefore, it is likely that the larger limb bud 
was mosaic and, thus, there were some cells that expressed the candidate gene. To confirm 
that heterozygous limb buds develop faster than the homozygous, but slower than the wild-
type limb buds it is necessary to perform further ISHs using more transgenic animals. Third 
batch of animals was injected for that purpose. At the time of the thesis submission the 
animals were still developing. 
To investigate the impact of the candidate gene knock-out on the proliferation speed of the 
mutant cells I decided to perform cumulative BrdU/EdU staining and estimate the length of 
the cell cycle in both, wild-type and mutant animals.  
A mosaic animal could be comprised of three different types of cells: i) the ones that have 
both wild-type alleles (wt+/+); ii) the ones with two knock-out alleles (wt-/-); or iii) a 
combination thereof (wt+/-). It can be speculated that those different kinds of cells would 
have different proliferative properties. I will therefore also correlate the cell cycle length to 
the composition of the mutant limb buds. 
Another line of evidence that the modified cells are slower was demonstrated by a follow-up 
amputation experiment using the animals from the batch 1. In that experiment the tails of 
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the animals, which showed delayed regeneration after the first round of amputation were 
amputated again slightly distally to the original amputation plane. The genotyping results of 
those animals demonstrated that the animals were highly mosaic. If the cell cycle of the 
mutated cells was delayed, then those cells would be selected against during regeneration. 
Subsequently, after the first round of regeneration the tails would be comprised of 
predominantly wild-type cells. Accordingly, the speed of the regeneration after the second 
amputation would be comparable in both, the mutant and the wild-type animals.  
As expected, I could not see any noticeable differences in the speed of regeneration 
between the mutant and the wild-type animals (FIGURE 3.32). 
FIGURE 3.32. Second round of tail regeneration. The tail of the animal that had a delay in the tail 
regeneration after the first amputation (red line) regrew at the same speed as the control after the 
second amputation (blue line). The black arrow indicates the direction of the dorso-ventral axis. 
Similarly, the limbs of the animals from the batch 1 also exhibited no regeneration 
abnormalities and delays after the second amputation. However, the delays in the 
regeneration after the first round of amputation were not as obvious as in the tail. 
Mosaicism of the animals from the batch 1 could also explain why different animals showed 
delays in either limb and tail regeneration, but not both simulteneously. One likely 
interpretation is that in a mosaic animal, which by chance had a critical mass of knock-out 
cells in the tail, the regeneration thereof would be delayed. The same might also hold true 
for the limbs.  
Although the experiment above gives a first feeling of the possible outcome, the above 
amputation experiments should be repeated using homozygous knock-out animals in order 
to get conclusive results. In homozygous knock-out animals I expect the tail regeneration to 
be delayed after several consecutive rounds of amputations. 
I planned further experiments to investigate the potential of the modified cells to contribute 
to the regenerate. I will create knock-out animals with the GFP background [SOBKOW ET AL. 
2006], select for homozygous knock-out animals and transplant the limb bud cells into those 
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of the white hosts. Afterwards, I will let the animals grow and amputate the limbs to follow 
the contribution of the GFP-positive cells to the regenerate.  
The expression pattern of the RFP reporter gene in the affected half of the knock-in animal 
and the delayed development of the limb bud in the same animal raised an interesting 
question: if the candidate gene was ubiquitously expressed throughout the half of the body, 
was the overall growth of the animal also affected? Unfortunately, this question could not be 
answered using a single knock-in animal and there were only three knock-out animals left 
after the IHC and ISH. However, while screening for developmental delays, I noticed that 
the animals with the delays in the limb bud progression also had abnormally shortened 
heads and disproportional bodies (FIGURE 3.33). 
 
FIGURE 3.33. Disproportional bodies. The bodies of the injected mutants (left and right) looked 
disproportional compared to the uninjected control animal (middle). 
Moreover, the tails of the animals with disorganized myotomes also looked slightly shorter 
than the tails of their wild-type siblings (data not shown). More homozygous knock-out 
animals are required to confirm those observations and link the genotype to the observed 
phenotype. However, the few remaining injected animals looked completely normal by the 
time of thesis submission. It can be speculated that similar to the limbs that eventually 
caught up in size with those of the uninjected controls, the bodies of the mutants also had 
an initial delay, which was caught up shortly after hatching. 
Surprizingly, the development of the hind limbs was not affected by the knock-out. 
However, the majority of the animals were were fixed for the IHC and ISH and, thus, did not 
start to develop the hind limbs by the time of fixation. Similar to the observations above, 
more animals are required in order to obtain conclusive and reproducible results. 
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CHAPTER 
4 
 
CONCLUSIONS 
 
Regeneration in a broader sense is the primary attribute of all organisms, since constant 
turnover of tissues is indispensable for survival. Subsequently there is no organism that is 
not capable of regenerating at least some structures or tissues. However, different tissue 
types and different species exhibit dramatically different regeneration potentials. While 
some organisms are only capable of regenerating a limited number of tissue types, others 
can replace substantial quantities of tissues.  
The regenerative potential is likely to be hierarchical in the sense that the lower 
invertebrates exhibit remarkable regeneration abilities and are on top of this hierarchy, while 
regeneration is significantly more restricted in higher vertebrates. 
Not only do species differ in their regenerative abilities, they also employ different 
mechanisms to restore the missing structures. Planarian regeneration is, for instance, driven 
by neoblasts – the resident stem cells [BAGUÑA ET AL. 1989; REDDIEN ET AL. 2004] that 
proliferate and give rise to all cell types of the body. In contrast, vertebrates are limited in 
the amount of the damage they can reconstitute and the regeneration is dependent on the 
formation of a specialized bud, or blastema, at the site of amputation. The blastema 
ultimately provides the tissue that forms the regenerate. 
The very process of regeneration is tightly coupled to other processes such as the asexual 
reproduction in planarians or the embryonic development in vertebrates. It is, however, still 
being debated whether the regenerative abilities arose in the course of evolution as the 
adaptive traits or are merely a by-product of another more general mechanism. 
Recent advents in molecular biological methods and computation science allow for 
comparisons of species exhibiting different degrees of regeneration potential or employing 
different mechanisms of regeneration. 
In the first part of this work I assembled the transcriptome of Ambystoma mexicanum, or 
the Mexican axolotl – one of the model organisms used in regeneration research. The 
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transcriptome assembly allows for insights into the molecular mechanisms of the axolotl 
limb and tail regeneration.  
Apart from regeneration studies, the assembled contigs could be used as anchors to guide 
the genome assembly from the genomic error-corrected PacBio reads. While it is not trivial 
to assemble a large number of reads at once, the transcriptome-guided assembly of the 
genomic loci is feasible, as only the reads that are homologous to the exons of the same 
gene are used. Moreover, I used the transcriptome to design a custom microarray that can 
be used for gene expression profiling and time course experiments. 
The transcriptome assembly allowed me to address the question, whether the regenerative 
abilities require specialized genes that are not present in non-regenerating species. I 
compared the axolotl transcriptome with that of the newt. I specifically searched for 
homologous transcripts that i) were not annotated in either species; ii) did not have 
homologs among the (non-regenerating) RefSeq organisms; iii) had a long open reading 
frame; and iv) were up-regulated during development and regeneration, but not in the 
mature tissue. 
I identified one candidate gene and created a number of knock-out animals to analyze its 
molecular function. While the results are not final, yet, and additional experiments are 
required, it is already apparent that the candidate gene knock-out causes delays in both, the 
limb bud progression and the limb and tail regeneration. 
The future plans are fairly straight-forward. First, the transcriptome assembly must be 
further improved, as many contigs are likely to represent fragments of the same transcripts. 
Second, the genomic loci of the genes should be assembled from the genomic PacBio reads 
to reconstruct intronic regions and the genomic regions up- and down-stream of the 
respective genes to allow for more advanced studies, epigenetic studies, for instance. In 
Xenopus different states of DNA methylation could be linked to differences in regenerative 
abilities between the regenerating tadpoles and non-regenerating adult animals [YAKUSHIJI ET 
AL. 2007]. 
Third, the molecular function of the candidate gene must be further investigated using a 
larger number of homozygous mutant animals. To this end, 8 animals from batch 1 were 
kept for future breeding. 
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